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Abstract 
The roles of Threonine-4 and Tyrosine-1 of the RNA Polymerase II C-
Terminal Domain: New insights into transcription from Saccharomyces 
cerevisiae 
Nathan Michael Yurko 
 
          RNA polymerase II (RNAP II) is responsible for transcribing messenger RNAs 
(mRNAs) as well as non-coding RNAs such as small nuclear RNAs (snRNAs) and 
microRNAs in eukaryotic cells. Rpb1, the largest catalytic subunit of this complex, 
possesses a unique C-Terminal Domain (CTD) that consists of tandem heptad repeats 
(the number varying from 26 to 52 by organism) with the consensus sequence of Tyr-
Ser-Pro-Thr-Ser-Pro-Ser (Y1S2P3T4S5P6S7). The CTD is extensively phosphorylated and 
dephosphorylated on non-proline residues during different steps of the transcription 
cycle, with roles for the threonine (Thr4) and tyrosine (Tyr1) attracting more attention. 
For example, in chicken cells, Thr4 functions in histone mRNA 3’ end formation, and 
Tyr1 phosphorylation is primarily associated with promoters and upstream antisense 
RNA formation, as well as preventing degradation of the polymerase, processes not 
found across all eukaryotes. A detailed introduction is described in Chapter 1.  
Taking advantage of the genetic tractability of yeast cells, we created a yeast (S. 
cerevisiae) strain with all CTD threonines substituted with valines (T4V) to study the role 
of CTD Thr4 in transcription in yeast, which prior to this study has been poorly 
characterized in S. cerevisiae. Using the T4V strain, we found that Thr4 was required 
for proper transcription of phosphate-regulated (PHO) and galactose-inducible (GAL) 
genes. We found genetic links between the T4V polymerase and genes encoding 
subunits of the Swr1 and Ino80 chromatin remodeling complexes, as well as the histone 
variant Htz1. We further provide evidence that CTD Thr4 is required for proper eviction 
of Htz1 by the Ino80 complex from genes requiring Thr4 for activation, presented in 
Chapter 2 of this thesis.  
          Finally, Chapter 3 describes the functions of CTD Tyr1 in S. cerevisiae. Using a 
strategy similar to the T4V strain, I created a strain expressing an endogenous Rpb1 
with all CTD tyrosine residues mutated to phenylalanine (Y1F). We found that this strain 
was viable, but with a severe slow-growth phenotype. We found genetic links between 
the Y1F polymerase and kinase/cyclin pair Srb10/Srb11, as well as an increase in 
occupancy on chromatin for the same. Further analysis indicated that RNA levels of 
genes associated with MAP Kinase associated stressors were dysregulated, and poly(A) 
site selection was biased towards distal poly(A) sites. Next, using an in vitro kinase 
assay, we showed Tyr1 phosphorylation on the CTD by MAP kinase Slt2, and in vivo 
CTD Tyr1 phosphorylation levels changed based on Slt2-associated stress response, 
as well as a decrease in in vivo Tyr1P-RNAP II from an Slt2 kinase-dead strain. 
Analysis of termination factors Nrd1 and Rtt103 showed transcription termination 
defects were likely the result of disruption of the interaction between the CTD interacting 
domains of these two proteins and the Y1F CTD. Extending this, we found additional 
disruptions in Slt2 recruitment to chromatin, increasing the depth of our knowledge of 
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          This thesis is divided into three chapters. Chapter 1 is an introduction to the 
research on the CTD of RNA polymerase II, specifically on Ser7, Thr4, and Tyr1, and 
parts will be published as a review article in Transcription. Chapter 2 is a research 
article entitled “Threonine-4 of the budding yeast RNAP II CTD couples transcription 
with Htz1-mediated chromatin remodeling”, published in PNAS (as Rosonina et al. 
2014). Chapter 3 is a manuscript with a title “MPK1/SLT2 links multiple stress 
responses with gene expression in budding yeast by phosphorylating Tyr1 of the RNAP 
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The C-terminal domain of the RNA polymerase II largest subunit (CTD) consists 
of a unique repeated heptad sequence of the consensus Tyr1-Ser2-Pro3-Thr4-Ser5-
Pro6-Ser7. An important function of the CTD is to couple transcription with RNA 
processing reactions that occur during the initiation, elongation and termination phases 
of transcription. During this transcription cycle, the CTD is subject to extensive 
modification, primarily phosphorylation, on its non-proline residues. Reversible 
phosphorylation of Ser2 and Ser5 is well known to play important and general functions 
during transcription in all eukaryotes. More recent studies have enhanced our 
understanding of Tyr1, Thr4 and Ser7, and what have been previously characterized as 
unknown or specialized functions for these residues has changed to a more fine-
detailed map of transcriptional regulation that highlights similarities as well as significant 
differences between organisms. Here, we review recent findings on the function and 
modification of these three residues, which further illustrate the importance of the CTD 
in precisely modulating gene expression. 
Introduction 
RNA polymerase II (RNAP II) is responsible for transcription of all mRNAs as well 
as a large and seemingly growing number of non-coding (nc) transcripts.  RNAP II is a 
highly conserved, multiprotein complex consisting of twelve subunits, the largest of 
which is Rpb1. The C-terminal domain of Rpb1 (CTD) is a unique protein domain 
consisting of a series of tandem heptad repeats of the consensus sequence Tyr-Ser-
Pro-Thr-Ser-Pro-Ser (YSPTSPS), although the exact number of repeats and deviation 
from this sequence varies between organisms. All steps in the synthesis of a mature 
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mRNA, or ncRNA, involve the CTD, as many different transcription and RNA processing 
factors associate with it in a dynamic manner throughout the transcription cycle. 
Modification of the CTD, principally phosphorylation, is important for many CTD 
functions. Phosphorylation occurs on all the non-proline residues, again in a dynamic 
manner with each residue/modification playing distinct roles. Two of these residues, 
Ser2 and Ser5, have garnered the most attention, and their functions are thus the best 
understood. Here we highlight the residues Tyr1, Thr4 and Ser7, which also play 
significant but perhaps more specialized roles in RNAP II transcription and regulation. A 
number of excellent reviews have been published concerning CTD modification and 
function, and the reader is referred to these for a broader picture of this unusual and still 
in many ways enigmatic protein domain (Hsin and Manley 2012, Corden 2013, 
Heidemann et al. 2013, Bentley 2014, Conaway and Conaway 2015).   
The CTD has several features that allow for fine-tuned regulation of polymerase 
function. The length itself varies from 26 to 52 heptad repeats, with the exact number of 
repeats depending on the species; budding yeast has a 26 repeat CTD with little 
variation, while vertebrate species, including humans, have 52 repeats (Corden 1990). 
These longer CTDs have more divergence from the consensus sequence in their more 
C-terminal repeats, whereas repeats closer to the N-terminus have less variation 
(reviewed in Liu et al. 2010, Hsin and Manley, 2012). Additionally, a 10-residue 
sequence is present at the C terminus of vertebrate CTDs that helps stabilize it 
(Chapman et al. 2004). The actual variation in CTD composition changes between 
species considerably, though. While CTDs from vertebrates show considerable 
similarity to each other, the CTD from D. melanogaster displays much more variation, 
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with only 3 of 45 repeats matching the consensus and with considerable divergence 
from a related organism, A. aegypti (Corden 2013). 
The CTD can be modified in multiple ways, more so in metazoans than in yeasts. 
Besides phosphorylation, the threonine and serine residues can be glycosylated 
(Zeidan and Hart 2010), and certain specific lysine residues can be ubiquitinated (Li et 
al. 2007) as well as methylated (Sims et al. 2011; Dias et al. 2015). These additional 
modifications occur primarily in metazoans, at least in part because S. cerevisiae and S. 
pombe CTDs do not have the non-consensus lysine residues. Cis/trans isomerization of 
the prolines functions to alter binding of proteins associated with the CTD; the 
peptidylprolyl-cis/trans-isomerase Ess1 in yeast (Pin1 in mammals) performs this 
function by binding to a Ser5P CTD, and by changing CTD conformation it can alter 
CTD phosphorylation dynamics (Hanes 2014). 
Most early studies focused on the processes affected by Ser2 and Ser5. Two 
recent studies employing mass spectrometry to analyze phosphorylation seem to 
vindicate this approach, as these residues were shown to be the most heavily modified, 
at least under the conditions analyzed (Suh et al. 2016, Schuller et al. 2016). As 
"orphaned" residues, Tyr1, Thr4 and Ser7 have become more of a focus in recent 
years, with a growing body of work dedicated to determining their function. We review 
below studies on these three residues and their place in modulating RNAP II function. 
Interesting themes that emerge are that these residues and their phosphorylation seem 
to affect more specialized genes and processes than Ser2/Ser5, and that significant 




Ser7 was the first of the “orphan” residues to receive significant attention. A 
schematic highlighting important functions, and illustrating some of the major 
differences between mammalian cells and yeast, is presented in Figure 1. Using the so-
called “α-amanitin system,” in which endogenous RNAP II is inhibited by the drug so 
that exogenous α-amanitin-resistant mutant forms of Rpb1 can be analyzed (Gerber et 
al. 1995), Egloff et al. found that a human Rpb1 derivative with all Ser7 residues 
mutated to A (S7A) was specifically defective in expression of certain small nuclear 
RNAs (snRNAs), in particular the spliceosomal U1 and U2 snRNAs (Egloff et al. 2007). 
Additionally, Ser7 phosphorylation was shown to facilitate interaction with Integrator, a 
12 subunit complex that functions in 3’ cleavage of snRNAs (Baillat et al. 2005, Egloff et 
al. 2007). Further studies showed that before Integrator binds, Ser7P is necessary to 
recruit the Ser5 phosphatase RPAP2, which stably associates with Integrator after 
binding the CTD (Egloff et al. 2010, 2012; Egloff 2012). Once RPAP2 is recruited, 
Ser5P is removed, leaving primarily a Ser7P/Ser2P CTD; Integrator subunit Int11 
requires both Ser7P and Ser2P for efficient binding (Egloff et al. 2010). The complexity 
of the proposed “CTD code” (Buratowski 2003) increased with better understanding of 
Ser7, as instead of general transcription mechanisms (as impacted by Ser2 and Ser5), 
the idea that a CTD residue can affect a specialized aspect of transcription, i.e., U 
snRNA 3’ end formation, came about. 
More recent studies have complicated somewhat the view of Ser7 in snRNA 
gene expression. Analysis of a chicken DT40 cell line expressing as the only source of 
Rpb1 a tetracycline (tet)-repressible derivative (tet-off) revealed that full viability in the 
presence of tet was restored by expression of an S7A derivative (Hsin et al. 2014). 
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Unexpectedly, U1 and U2 transcription, and 3’ processing, were completely normal in 
these cells, which contrasts with the results described above (Egloff et al. 2007).  While 
it is possible that the discrepancy reflects differences between chicken and humans, this 
seems unlikely due to the high conservation of all factors involved. Instead, the results 
of Egloff et al. may involve a synthetic effect between S7A and α-amanitin, as the 
inhibitor can lead to degradation of several proteins, including the elongation factor 
DSIF (Tsao et al. 2012), known to be important for snRNA expression (Mandal et al. 
2004). However, other results of Hsin et al. (2014) do support, albeit indirectly, a role for 
Ser7 in snRNA 3’ processing. While DT40 cells expressing an Rpb1 variant with only 
repeats 1-26 was entirely viable and snRNA processing unaffected, a derivative with 
repeats 27-52 was inviable and showed a dramatic and specific decrease in snRNA 3’ 
processing. A parsimonious explanation for these results is that 20 of the 26 position 7 
residues in the C terminal half of the CTD are not Ser. Since many of these are non-
conservative changes, e.g., Lys, perhaps this is sufficient to disrupt Integrator 
interaction and hence U snRNA 3’ processing. 
The idea that CTD codes might be different for different organisms also arose 
from studies of Ser 7. For example, snRNA 3’ ends in S. cerevisiae are not formed by 
Integrator, which does not exist in yeast, but instead by the Nrd1-Nab3-Sen1 (NNS) 
complex, which primarily recognizes CTD Ser5P (Vasiljeva et al. 2008), and conversely 
the NNS does not appear to exist in vertebrate cells (Egloff et al. 2012, O’Reilly et al. 
2014). Even within yeasts, there appear to be differences in Ser7 function. In S. pombe, 
CTD Ser7 has been associated with mRNA capping (traditionally associated with Ser5), 
as Ser7P is one of the components that enables efficient binding of 5’-cap 
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methyltransferase Pcm1 to the CTD (St. Amour et al, 2012). Additionally, S7A mutation 
in S. pombe leads to reduced histone H3K4 and H3K36 trimethylation, and also 
exacerbates the effects of elongation factor Spt5 mutants (Mbogning et al. 2015). The 
same S7A mutation also led to de-repression of the PHO1 gene, while the phospho-
mimetic S7E caused hyper-repression, which points to a role for Ser7 in phosphate 
homeostasis in fission yeast (Schwer et al. 2015). However, in S. cerevisiae, no 
concrete function has yet been assigned to Ser7. 
Despite the lack of a clear function, Ser7 is indeed phosphorylated in S. 
cerevisiae. Ser7P was found globally on transcribing RNAP II (Chapman et al. 2007), 
and the TFIIH kinase Kin28/Cdk7 was shown to phosphorylate Ser7 in vitro and to be 
required in vivo, and across organisms (Kim et al. 2009, Akhtar et al. 2009). As this 
kinase has already been associated with not only Ser5 phosphorylation but also mRNA 
capping (Komarnitsky et al 2000, Schroeder et al 2000), that similar associations with 
Ser7 phosphorylation exist is perhaps not surprising. Additionally, the CTD kinase Bur1 
also shows Ser7 phosphorylation activity distal to promoters of highly transcribed 
genes, consistent with the role of Bur1 in elongation (Tietjen et al. 2010). How Ser7 is 
dephosphorylated is less clear. Ser7P is not a target of Rtr1 (a Ser5 phosphatase, 
though there is some question about this; see Xiang et al. 2012), but Ssu72 (another 
Ser5 phosphatase; Krishnamurthy et al. 2004) has been shown to have Ser7 
dephosphorylation activity (Mosley et al. 2009, Zhang et al. 2012).  
In human cells, RNAP II is known to be the target of a different modification, 
glycosylation (Kelly et al. 1993). The enzyme O-GlcNAc transferase (OGT) glycosylates 
both Ser5 and Ser7, and has been suggested to assist in proper preinitiation complex 
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formation (Ranuncolo et al. 2012). Despite the ubiquitous nature of Ser7 
phosphorylation across eukaryotes, glycosylation does not exist in yeast, and the 
primary findings from work on Ser7 highlight that the variation between organisms is 
significant and can have important implications for the function of these residues across 
species. Going forward, it will therefore be wise to consider carefully differences 
between organisms, and how some mechanisms in one species may be repurposed or 
removed in another. 
Threonine-4  
Differences between organisms’ use of the CTD became increasingly apparent 
as Thr4 was explored on the heels of Ser7. (Figure 2 highlights the functions of Thr4 
across species.) For example, in chicken DT40 cells, using the same approach as 
described above for Ser7, Hsin et al. found that Thr4 was both essential for viability and 
necessary for efficient 3’ end processing of non-polyadenylated replication-dependent 
histone transcripts, as processing (but not transcription) of these mRNAs, and 
recruitment of histone 3’ processing factors, was reduced in cells expressing a T4V 
CTD derivative (Hsin et al. 2011). This immediately suggested a difference between 
yeast and vertebrates, as yeast histone mRNA 3' ends are polyadenylated like all other 
mRNAs (Marzluff et al. 2008). Hsin et al. also compared levels of poly-A+ transcripts as 
well as U1 snRNA levels and found no changes (setting Thr4 apart from Ser2 or Ser7 
function), bolstering the case for specialization. Extending this to mammalian cells, 
ChIPseq analyses showed an increase in Thr4P signal in the 3’ region of genes, and a 
T4A mutant showed a lethal phenotype (analogous to T4V in DT40 cells) as well as an 
apparent genome-wide elongation defect, as determined by elevated levels of promoter-
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proximal RNAP II and lower levels at 3’ ends of genes (Hintermair et al. 2012). It should 
be noted that Hsin et al. also observed small increases in promoter-proximal RNAP II on 
several genes (Hsin et al. 2011). Whether the greater effects on elongation observed by 
Hintermair et al. were due to differences between chicken and human cells or to the use 
of the α-amanitin system as described above is not clear. Recently, a cell-cycle link was 
extended to Thr4, as Thr4-phosphorylated RNAP II was found to associate with 
centrosomes (across all cell-cycle phases save interphase) and the midbody in M phase 
HeLa cells (Hintermair et al. 2016).  
While Thr4 is essential for viability in vertebrates, this is not the case in S. 
cerevisiae. Substitutions with Ala are well-tolerated by yeast, even when paired with an 
S7A derivative (Stiller et al. 2000). RNAP II with Thr4P was found globally on chromatin, 
suggesting a role in transcription, while distribution after the poly-A site was lower 
(Mayer et al. 2012). Consistent with this, in a subsequent study Thr4 phosphorylated 
RNAP II was detected exclusively in the chromatin fraction, and properties of a T4V 
derivative linked Thr4 to chromatin remodeling and histone eviction from promoters of 
genes required for survival under low-phosphate conditions (PHO genes) and for 
galactose metabolism (Rosonina et al. 2014). Normally, the repressive histone dimer 
H2A.Z/H2B is evicted from these promoters for such genes by chromatin remodeler 
INO80 during activation. In the T4V cells, this process was defective, and as a result the 
cells, which are fully viable in rich media, are inviable in phosphate-depleted or 
galactose-containing media. Schwer et al. found that expression of PHO genes was 
also dysregulated in S. pombe (Schwer et al. 2014). These results together are again 
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consistent with Thr4 being involved in relatively specific functions, which differ between 
yeast and mammalian cells.  
More recent studies have however suggested broader roles for Thr4 in yeast, 
specifically in transcription termination and post-transcriptional splicing. Comparing 
Ser5P and Thr4P RNAP II interactomes, Harlen et al. found Thr4P devoid of 
spliceosomal components (associated with co-transcriptional splicing) (Harlen et al. 
2016). Additional RNA analysis found that the T4V mutant partially retains introns in 
90% of post-transcriptionally spliced genes, and a reanalysis of RNA-seq data of 
Rosonina et al. was consistent with a modest splicing defect. A proteomics analysis 
found that the known CTD-interacting protein Rtt103 (but not the exonuclease complex 
Rat1/Rai1, which function together in transcription termination) was found to associate 
with the Thr4P CTD. NET-seq analysis, which precisely maps the positions of 
elongating RNAP II, revealed an increase in RNAP II occupancy at poly(A) sites, where 
Rtt103 occupancy would be the highest, in a T4V mutant strain, similar to rtt103Δ cells. 
RNA-seq analysis replicated a global downstream shift of poly(A) site selection 
observed by Rosonina et al. (2014), consistent with a reduction of 3’ end cleavage. 
More recent NET-seq experiments extended these findings to human cells, as Thr4P 
was found to correlate with termination in regions of protein-coding genes (Schlackow et 
al. 2017).  
The termination defect itself comes about when Rtt103 cannot effectively bind 
the CTD (such as in the T4V mutant), which prevents effective RNAP II disengagement 
from chromatin and continued transcription past the poly(A) site. An additional study 
using a T4A mutant found that this termination defect also affects a subset of snoRNA 
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genes, and this was distinct from a known Ser2P requirement (Nemec et al. 2017). 
Additionally, NMR studies revealed that the Rtt103 CTD interacting domain (CID) binds 
to a Thr4P CTD as well as a Ser2P CTD, but the presence of both together inhibits 
binding (Jasnovidova et al. 2017). While no study suggests that Thr4 is necessary 
globally for transcription, there is some question as to how prevalent Thr4P is in yeast, 
with one estimate at only 2% of Ser2P levels (Suh et al. 2016) and another suggesting it 
is as abundant as Ser2P (Schuller et al. 2016). 
There are currently two candidates, not mutually exclusive, for the Thr4 kinase. 
Initially, it was reported that CDK9 was necessary for Thr4 phosphorylation in DT40 
cells, as inhibiting CDK9/P-TEFb with DRB or flavopiridol inhibited Thr4 phosphorylation 
(Hsin et al. 2011). Importantly, this did not reflect a requirement for Ser2P, as Thr4P 
was detected on an S2A derivative. Additionally, siRNA-mediated knockdown (KD) of 
CDK9 also decreased Thr4P in human 293 cells, and purified Cdk9 phosphorylated 
Thr4 in vitro (Hsin et al. 2014). A role for CDK9 in Thr4 phosphorylation is consistent 
with earlier studies on histone 3’ end processing, since CDK9 KD resulted in increased 
RNAP II read-through of the natural 3’ end site to a downstream polyadenylation signal, 
resulting in an increase in poly-A+ histone mRNA (Pirngruber et al. 2009). Other studies 
indicate that Polo-like kinases Plk3 and Plk1 are involved with Thr4 phosphorylation. 
Plk3, active throughout the cell cycle and playing additional roles in hypoxic stress 
response, although principally nucleolar (Zimmerman and Erickson 2007), was found to 
phosphorylate Thr4 in vitro and KD in HeLa cells reduced Thr4P by 50% (Hintermair et 
al. 2012). Plk1, an M-phase specific kinase associated with RNAP II in centrosomes 
and the midbody, was also found to phosphorylate Thr4 in vitro, and mutation of Thr4 
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(T4A) inhibited M phase progression (Hintermair et al. 2016). It is certainly possible that 
both Cdk9 and Plk1/3 target Thr4 under different conditions, as multiple kinases seem 
to target all other CTD residues. Indeed, Ser5 is also targeted in M phase, with the help 
of Pin1, by Cdc2/CylinB (Xu et al. 2003). The identity of the Thr4 kinase(s) in S. 
cerevisiae, and whether Cdk9 or Plk homologues are involved, is currently unknown.  
Fcp1, well known to dephosphorylate Ser2 at gene 3’ ends (Cho et al. 2001), 
also appears to be a Thr4 phosphatase. The enzyme was shown to dephosphorylate 
Thr4 in vitro, and Fcp1 KD in vivo increased Thr4P levels in 293 cells (Hsin et al. 2014). 
Tyrosine-1  
Determining the roles of Tyr1 phosphorylation has connected early successes 
with ongoing mystery. Much like Ser7 and Thr4, it was apparent very early on that 
significant differences between metazoan and yeast exist concerning Tyr1 (as illustrated 
in Figure 3). Tyr1 was discovered to be phosphorylated in mammalian cells relatively 
quickly, but by a kinase, c-Abl, that has no known yeast equivalent (Baskaran et al. 
1993, 1999).  As to function, Tyr1P was found many years later to be present on RNAP 
II at transcriptional enhancers and promoters in human cells, albeit in the antisense 
direction (Descostes et al. 2014). These findings are not limited to mammalian cells; 
upstream antisense RNAs (uaRNAs) were found to accumulate in DT40 cells when an 
Rpb1 containing Y1F substitutions was expressed (Hsin et al. 2014). This increase in 
uaRNA accumulation was not due to increased transcription (RNAP II levels were in fact 
decreased) and thus appears to be due to increased stability of these naturally unstable 
RNAs. As in human cells, Tyr1P levels on upstream regions affected by the Y1F CTD, 
but not on the corresponding downstream sense genes, were elevated. From these 
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studies, it appears that “antisense” RNAP II is excessively Tyr1 phosphorylated, and 
this in some way facilitates turnover of uaRNAs. Both of these studies, which employed 
either the α-amanitin (Descostes et al. 2014) or tet-off (Hsin et al. 2014) system, found 
that Y1F substitutions were lethal following inhibition of the endogenous Rpb1. 
Unexpectedly, Tyr1P also plays an important role in maintaining CTD stability in 
vertebrate cells. A Y1F-derivative expressed in DT40 cells was shown to be present at 
lower levels compared to a WT derivative, and a low molecular weight Rpb1 form 
lacking the CTD was observed (Hsin et al. 2014). Remarkably, CTD stability (but not 
cell viability) could be completely restored by a single Tyr residue in the final heptad. 
Furthermore, in vitro assays showed that the CTD of a GST-CTD derivative could be 
completely degraded by purified 23S proteasomes, but a derivative Tyr1 
phosphorylated by c-Abl was stable, implicating Tyr1 phosphorylation in CTD stability. 
Perhaps in keeping with this function Tyr1P was the only CTD phosphorylation found on 
cytoplasmic/nucleoplasmic (as opposed to chromatin-associated) RNAP II. Related 
results were observed in human cells, as a truncated Rpb1 apparently lacking the CTD 
was observed in cells expressing a Y1F derivative (Descostes et al. 2014). 
The hunt for Tyr1 function in yeast cells has been more challenging. A truncated 
Y1F Rpb1 derivative (12 repeats) was shown to be lethal in S. cerevisiae (West and 
Corden 1995), but more recent experiments found that a similar truncated derivative 
was viable with only minor growth defects in S. pombe (Schwer and Shuman 2011). In 
contrast, in S. cerevisiae a full-length Y1F Rpb1 was viable, but displayed a severe slow 
growth phenotype (Rosonina et al. 2014, Yurko et al. 2017 [manuscript submitted]). The 
reason(s) for these discrepancies is unclear, but suggest differences not just between 
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yeast and vertebrates but also between budding and fission yeasts themselves. Also at 
play may be differences in the lengths/composition of the CTDs analyzed, which could 
lead to synthetic effects.  
Several studies have begun to provide insight into the precise functions of Tyr1 
and its phosphorylation in yeast. The pattern of Tyr1P globally was shown to resemble 
that of Ser2P, with the minor difference of a reduction in Tyr1P before the decrease in 
Ser2P at gene 3’ ends (Mayer et al. 2012). By measuring binding affinities of several 
termination factor CIDs to CTD diheptad phosphopeptides, it was suggested that Tyr1P 
impairs termination factor recruitment to the CTD, specifically preventing Nrd1 
association after promoter clearance and enabling Pcf11 and Rtt103 to bind to Ser2P-
CTD after the drop in Tyr1P at 3’ ends (Mayer et al. 2012). CIDs from all three of these 
proteins were shown to bind Ser 2P (or Ser5P, for Nrd1) CTD peptides but not Tyr1P-
containing versions. Rtt103 in fact requires an intact and unmodified Tyr1 residue, since 
it can only bind efficiently to Ser2P-CTD peptides if a specific Asn residue can form a 
hydrogen bond with the hydroxyl group of Tyr1 (Lunde et al. 2010). Extending these 
results, Y1F mutation was found to disrupt Rtt103 binding to the CTD and impair Nrd1 
recruitment to chromatin (Yurko et al. 2017, manuscript submitted). Aside from the 
Nrd1/NNS complex, the presence of Tyr1P during elongation and near gene 3’ ends 
also promotes association of elongation factor Spt6, which has an SH2 domain that 
specifically recognizes Tyr1P and serves as a histone chaperone, with the CTD, thus 
linking the Tyr1 with elongation-promoting histone modifications (Burugula et al. 2014). 
While not all of these findings can extend to vertebrate cells, since the NNS complex 
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does not appear to exist outside of yeast, some overlap with Rtt103 (in vertebrates, 
Kub5-Hera) and Spt6 exists, though exactly how much is still in question. 
The kinase(s) and phosphatase(s) responsible for modifying Tyr1 differ between 
yeast and vertebrate organisms. The protein kinase c-Abl was identified many years 
ago as a likely Tyr1 kinase in mammalian cells (Baskaran et al. 1993, 1999). c-Abl, a 
known nuclear tyrosine kinase, was shown to phosphorylate RNAP II Tyr1 efficiently in 
vitro. It contains both an SH2 domain that precedes its catalytic domain and is required 
for catalytic domain activation and efficient, near stoichiometric phosphorylation, and 
also a CTD-interacting domain specific for RNAP II. A c-Abl-related kinase, Arg, was 
also shown capable of phosphorylating Tyr1 in vitro (Baskaran et al. 1997). The precise 
roles of these kinases in vivo, and whether other Tyr1 kinases exist in mammalian cells, 
remains to be determined.  
Determining the identity of the Tyr1 kinase(s) in yeast has been more 
challenging. This reflects in part the fact that that Tyr phosphorylation in budding yeast 
is very rare, constituting <0.1% total phosphorylation (Modesti et al. 2001; Chi et al. 
2007). Furthermore, there is no yeast homolog of c-Abl, and the only known SH2 
domain-containing protein is, interestingly, the Tyr1P-interacting protein Spt6 (Diebold 
et al. 2010). Recent work though has identified the MAP kinase Slt2/Mpk1 (Pearson et 
al. 2011) as a Tyr1 kinase in S. cerevisiae (Yurko et al. 2017 [manuscript submitted]). 
Slt2 phosphorylates Tyr1 in vitro, and in vivo Slt2 is necessary for full Tyr1 
phosphorylation and also modulates Tyr1P levels during stress responses, which were 
found to rise following for example cell wall stress and heat shock. Interestingly, Slt2 
also regulates other aspects of the transcription machinery, such as the Mediator 
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kinase/cyclin pair Srb10/11 (by phosphorylating Srb11) (reviewed in Strich and Cooper 
2014), which is retained on chromatin in cells expressing the Y1F derivative (Yurko et 
al. 2017 [manuscript submitted]). 
 Glc7 appears to be the principal Tyr1 phosphatase in yeast. Glc7 was initially 
identified as a Ser-Thr phosphatase and plays a number of roles, for example as a 
subunit of the cleavage and polyadenylation factor (CPF) complex (Nedea et al. 2003) 
and as a required factor in the cell wall integrity pathway (Andrews and Stark 2000). 
Schreick et al. found that Glc7 dephosphorylates Tyr1P in vitro and, as a component of 
CPF, is required for Tyr1P dephosphorylation at the polyadenylation site, for recruitment 
of termination factors Pcf11 and Rtt103, and for termination (Schreick et al. 2014). 
These findings are consistent with other results that link both NNS (Nrd1) and Rtt103-
dependent termination with control of Tyr1 phosphorylation (Mayer et al. 2012; Yurko et 
al. 2017 [manuscript submitted]). Another potential candidate for Tyr1 
dephosphorylation, Ssu72, is also a subunit of the CPF complex (He et al. 2003), and 
has structural homology with a class of protein tyrosine phosphatases termed low 
molecular weight PTPs (Meinhart et al. 2003). However, Ssu72 does not show any Tyr 
phosphatase activity in vitro, preferring to dephosphorylate Ser5 (Xiang et al. 2012).  
Modifying the CTD 
Since the CTD is heavily phosphorylated, one of the most common strategies 
used to determine its functions has been to mutate the CTD to prevent or mimic 
phosphorylation. The earliest attempts to do this systematically utilized a plasmid-based 
system with several CTD substitution mutants (West and Corden 1995). By using a 
system where unmodified polymerase could be removed and replaced with a partially- 
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or fully-substituted synthetic variant, initial observations of phenotypes and viability were 
determined; initial findings indicated that Ser2 and Ser5 were necessary for viability. 
However, truncated CTD S2A transition mutants in fission yeast were found to be 
viable, and along with Tyr1 regulate the expression of iron uptake genes but otherwise 
show modest changes in global gene expression (Saberienfar et al. 2011, Schwer et al. 
2014). Generating a full-length CTD S2A in S. cerevisiae and integrating it into the 
genome (instead of using a plasmid-based system) has also shown that this mutation is 
viable, but slow-growing and bearing similarity to a Ctk1 deletion strain (Cassart et al. 
2012). Mutations in Ser5 so far have been shown to be unequivocally lethal, although 
attaching capping enzyme directly to the CTD restores viability, indicating that this 
lethality is a result of a failure to properly cap mRNA (Liu et al. 2008, Schwer and 
Shuman 2011). Interestingly, Ser7 has been consistently shown to be the most 
dispensable, as generating a full-length S7A mutant has shown little effect on mRNA 
levels in human cell lines, but are not able to efficiently process snRNAs or facilitate 
interaction with the Integrator complex (Egloff et al. 2007, Chapman et al. 2007). 
Although S2A and S5A transitions were initially considered lethal, this may have 
been due to synthetic effects from the constructs used. It is necessary to note that the 
initial plasmid-based system was using truncated CTDs, which were also used to 
determine a minimum number of repeats for viability (approximately 8 consensus 
repeats) (West and Corden 1995). Using full-length chromosomally-integrated 
constructs can produce different results, since reductions in CTD length cause slower 
growth under normal conditions, whereas CTD constructs closer to wild-type length but 
with fewer consensus repeats grow much more favorably compared to shorter CTD 
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constructs unless stress is applied (Liu et al. 2010). A truncated CTD has been 
connected to increased synthetic effects with the Ras/PKA signaling pathway, as a 
truncated CTD and a RAS2 mutant showed similar defects upon nutrient deprivation 
(Howard et al. 2002). A shorter CTD has also been linked to changes in expression of 
Ty1 elements and Cdk8-mediated phosphorylation of the CTD (Aristizabal et al. 2015). 
Applying this strategy of introducing a modified CTD has continued for Thr4 and 
Tyr1. Changing Thr4 to alanine has so far been uniformly lethal, excepting in fission 
yeast where it is still lethal on its own, but a double T4A-S7A mutant is viable (Schwer 
et al 2014), and in chicken cells the more conservative change to valine is also lethal 
(Hsin et al. 2011). A key change in Hsin et al. that enabled study of the T4V in chicken 
cells was the use of a tet-inducible system, which has been used previously to study 
other transcription factors (Wang et al. 1996; Takagaki and Manley 1998), but 
previously not RNAP II directly in a vertebrate system. The major finding from the paper, 
that Thr4 is required for recruiting 3’ end processing factors to histone genes 
specifically, led to the idea that certain residues can affect fine-tuned and specific 
transcriptional programs, similar to the growth condition-specific patterns discussed 
above. In this case, the use of an inducible system is important to bypass the 
consequences of lethality of the change. Since that phenomenon is not present in all 
eukaryotes, investigating the effects of a T4V substitution in S. cerevisiae found instead 
a link between Thr4, the Ino80 complex, and the use of histone variant H2A.Z at a 
subset of promoters, linking RNAP II with chromatin remodeling at specific genes 
(Rosonina et al. 2014). Additional analysis using the T4V substitution revealed 
interactions between Rtt103 and CTD Thr4P, as well as a related post-poly-A 
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transcriptional defect leading to increased RNAP II density after poly-A sites and an 
increase in intron retention (Harlen et al. 2016). It is possible these findings extend to 
human cells as well, since Thr4P correlates with termination in regions of protein-coding 
genes, but the lethality of the T4V change in mammalian cells frustrates direct 
assessment (Schlackow et al. 2017). 
Applying this strategy to Tyr1 has only recently been fruitful, since multiple 
groups have found that inserting a Y1F substitution CTD has generally resulted in 
lethality (West and Corden 1995, Descostes et al. 2014, Hsin et al. 2014). Much like the 
T4V substitution, a Y1F inducible construct in chicken cells also displays a lethal 
phenotype, but degradation of the mutant polymerase was also found, unlike other 
constructs (Hsin et al. 2014). Thus, a consensus repeat was added at the end, which 
still showed a phenotype but halted premature degradation of the polymerase. Only Y1F 
mutant CTDs in yeasts have been reported as being viable, and in the case of 
S. pombe no unusual growth defects aside from cold and iron sensitivity have been 
reported (Schwer et al. 2014). Recently, a full-length Y1F substitution CTD was 
integrated into the S. cerevisiae genome, and despite a severe growth defect was found 
to be viable, affecting the SLT2 pathway (and being a target for SLT2 phosphorylation) 
(Yurko et al. 2017 [manuscript submitted]). Part of this apparent disconnect may be that 
the Tyr1 residue is not used as much in yeasts compared to other organisms, as a CTD 
modified for mass spectrometry exhibited very little in vivo Tyr1 phosphorylation, despite 
the use of a recombinant Abl kinase to phosphorylate it in vitro (Suh et al. 2016). 
Another possible reason is that the Tyr1 residue may have a more specialized use in 
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yeasts, such as stress response (Schwer et al. 2014, Yurko et al. 2017 [manuscript 
submitted]), and so may be dispensable under normal conditions. 
Chromatin Modification and the RNAP II CTD 
Dynamic modifications to the RNAP II CTD go hand in hand with changes to the 
underlying chromatin structure of expressed genes. The histones that make up 
chromatin structure are the targets of several modifications, depending on the phospho-
state of the CTD, the most prominent (excepting ubiquitination) being acetylation, 
phosphorylation, and methylation (reviewed in Bannister and Kouzarides 2011). 
Acetylation of lysines in the N-terminal tails of core histone proteins leads to the removal 
of positive charge that prevents folding of chromatin, leading to an open chromatin 
structure and enabling access of DNA for transcription (Verdin and Ott 2015). 
Phosphorylation is primarily linked to the DNA damage response, but H2B Tyr37 and 
H3 S10 phosphorylation have also been shown in yeast to either impair transcription or 
regulate the transcription of certain classes of genes, such as those required for 
sporulation or ribosomal biosynthetic genes (Rossetto et al. 2012; South et al. 2013). 
Methylation of histones can occur on all basic residues (arginines, lysines, and 
histidines), and lysine methylation can be either associated with transcriptional 
activation (ex. H3K4me3) or repression (ex. H3K36me2); control of gene expression 
this way is done either through methyltransferases such as through COMPASS/Set1 for 
H3K4 trimethylation and Set2 for methylation of H3K36, or by compacting chromatin 
(Miller et al. 2001; Butler and Dent 2012; Greer and Shi 2012). Other modifications 
exist, such as isomerizing the proline residues, which can help fine-tune transcriptional 
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response by preventing Set2-mediated lysine methylation (Nelson et al. 2006; Monneau 
et al. 2013).  
When RNAPII begins transcription, CTD Ser5P is enriched at promoters and the 
5’ ends of active genes; this peak is gradually removed as transcription progresses and 
Ser2P levels increase (Mayer et al. 2010). Ser5 phosphorylation (along with H2B 
ubiquitination) is necessary for the recruitment of Set1, a histone methyltransferase that 
methylates the Lysine 4 on H3 (H3K4); this is done through the Paf1 complex recruiting 
COMPASS, which contains Set1 (Krogan et al. 2003). Set1 then works with the histone 
demethylase, Jhd2, to either set the conditions for transcriptional activation (H3K4me3) 
or repression (H3K4me2) (Ramakrishnan et al 2016). The need for differential 
methylation of H3K4 becomes apparent when cells need to activate or repress certain 
genes in response to different stress conditions. For example, resistance to Brefeldin A 
requires Set1 activity to activate expression, while exposure to diamide stress leads to 
repression of ribosomal biosynthetic genes coupled with H3S10 phosphorylation 
(Weiner et al. 2012, South et al. 2013). The recruitment of Set1 and resulting 
trimethylation of H3K4 due to CTD Ser5P enrichment can also lead to Nrd1 recruitment, 
which would lead to transcription termination as it applies to cryptic unstable transcripts 
and snoRNAs (Terzi et al. 2011). The choice between Nrd1-mediated termination and 
continuing transcription requires the interaction of other factors and is context 
dependent, one example being Slt2 which serves to recruit the Paf1 complex and 
blocks the Nrd1-Pol II interaction, mediated by Swi4/Swi6 protein complex (SBF) (Kim 
and Levin, 2011). This mechanism is especially important for the induction of stress-
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responsive genes, which require immediate active transcription to enable proper 
response. 
Once transcription is underway and the CTD transitions from primarily Ser5P to 
Ser2P, elongation associated factors are recruited to the RNAP II CTD and chromatin to 
enable efficient elongation. The kinase primarily associated with Ser2 phosphorylation is 
Ctk1 in budding yeast (CDK12 in mammals), although Bur1 has also been shown to 
phosphorylate Ser2 near the promoter (Sterner et al. 1995, Cho et al. 2001, reviewed in 
Hsin and Manley 2012). There is some overlap in their function; both kinases help 
recruit the RSC chromatin remodeler by interacting with SAGA and NuA4 histone 
acetyltransferases, and together recruit Spt6 to the 5’ ends of genes (Spain et al. 2014, 
Burugula et al. 2014). Despite this, the two kinases are likely to represent different 
aspects of these functions, since deleting CTK1 primarily affects CTD Ser2 
phosphorylation closer to the 3’ end, and Bur1 interacts directly with the CTD Ser5P 
followed by Ctk1 recruitment (Qiu et al. 2009). This represents a simplified order of 
events, as Bur1’s interaction with the CTD Ser5P means it acts upstream of Ctk1 and 
Spt6 recruitment, both of which interact with other machinery such as the Paf1 complex 
in order to maintain stability throughout elongation (Dronamraju and Strahl 2014). 
Conversely, Fcp1 is considered to be the primary Ser2 phosphatase as it associates 
with RNAP II and has Ser2 dephosphorylation activity.  In addition, cells lacking 
transcriptional activator SUB1 show decreased association of Fcp1 to the CTD, 
changing the phospho-pattern of the RNAP II CTD (Cho et al. 2001, Kong et al. 2005, 
Calvo and Manley 2005). 
23 
 
As Ser2 is phosphorylated, the histone methyltransferase Set2 is able to directly 
recognize and bind to CTD Ser2P, providing the sole methyltransferase activity for 
H3K36 in S. cerevisiae (Wagner and Carpenter 2012, Tanny 2014). Besides Set2, 
H3K36 trimethylation also requires Spt6, as Spt6 influences Set2 protein levels and is 
necessary for H3K36 trimethylation when Set2 levels are normal. However, the SH2 
domain of Spt6 is not required for this (Youdell et al. 2008). The chromatin modification 
aspect of Spt6 has also been observed in S. pombe since it is required for both 
H3K36me3 and H3K4me3 levels to repress antisense transcription (DeGennaro et al. 
2013). It should be noted that Spt6, while identified initially as interacting with CTD 
Ser2P (see Youdell et al. 2008), has been identified as better interacting with CTD 
Tyr1P in yeast, consistent with the characterization of the SH2 domain and crystal 
structure studies (Liu et al. 2011, Close et al. 2011). Part of the confusion in 
S. cerevisiae may result from the fact that Tyr1 and Ser2 phosphorylation of the CTD 
have similar patterns until the 3’ ends of genes, where Spt6 levels and CTD Tyr1P 
levels drop, and that tyrosine phosphorylation in yeast is considered rare and poorly 
characterized. In addition, in vitro binding of Spt6 to CTD Ser2P makes it harder to 
dissect out the specific roles of Tyr1P and Ser2P (Sun et al. 2010; Mayer et al. 2011, 
2012). Despite this, the roles of Set2 and Spt6 in modifying histones to enable 
transcription are clear, and Ser2P on the RNAP II CTD Ser2P along with the rest of the 
elongating polymerase provides a point from which many factors combine and enact 
changes to the chromatin. 
In addition to the interplay of histone and CTD modifications, there exist also 
some histone variants in yeast. Besides the core histones (H2A and B, H3, H4), yeast 
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also has an essential centromeric H3 (CSE4), nonessential H2A variant H2A.Z, and an 
H1 (reviewed in Eriksson et al. 2012). CSE4 (or CENP-A in mammals) is required for 
formation of the centromere with H4 on chromosomes, and assembly of the 
kinetochore, but is otherwise not involved in transcription (Quenet and Dalal 2012). H1 
in yeast, while not required for viability, may be responsible for more subtle aspects of 
chromatin structure, such as longer chromatin loops without this histone (Georgieva et 
al 2012). It has also been linked to meiotic recombination during sporulation in yeast 
through binding to meiotic gene promoters by Ume6 (as part of the Rpd3L histone 
deacetylase complex), and inhibits homologous recombination in vegetative cells, 
although this view has been challenged recently as sporulation and meiosis were not 
impaired in H1 deletion cells (Bryant et al. 2012, Brush 2015). The histone variant 
H2A.Z, however, is much more relevant to transcription. 
Conserved from yeast to human, H2A.Z is a histone variant that replaces histone 
H2A in primarily promoter-associated nucleosomes (reviewed in Henikoff and Smith 
2015). By placing H2A.Z so close to the transcription start site under normal conditions, 
the expression of genes poised for activation can be regulated at the chromatin level. 
H2A.Z’s deposition at promoters requires Swr1 (and in some cases Tup1), whereas its 
removal is thought to involve Ino80, but possibly not under all conditions (Zhang et al. 
2005, Gligoris et al. 2007, Tramantano et al. 2016). However, under conditions of 
phosphate depletion or galactose induction, H2A.Z is rapidly removed from promoters to 
enable transcription of target genes such as PHO5 and GAL1, and the Ino80 complex in 
combination with Thr4 phosphorylation of the RNAP II CTD connects this chromatin 
remodeling with the activity of the polymerase (Rosonina et al. 2014). Besides this 
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activity for active transcription, H2A.Z has been suggested to affect post-transcriptional 
mechanisms as well; in Rrp6 mutants, H2A.Z is also found in 3’ ends of genes 
associated with antisense transcription start sites, and H2A.Z deletion corresponds to 
down-regulation of these antisense transcripts (Gu et al. 2015). Reconciling these 
findings with each other, it is possible that Ino80’s role in H2A.Z removal is limited to 
specific promoters, as previous experiments with upstream activation sequences of 
many PHO and GAL genes have shown (Ebbert et al. 1999, Barbaric et al. 2007). 
Termination and the RNAP II CTD 
Once RNAP II reaches the 3’ end of a gene, and the CTD is primarily Ser2P, the 
3’ end processing machinery arrives to the 3’ UTR and polyadenylates the nascent 
mRNA. To this end, many 3’ end factors have CTD Interacting Domains (CIDs) that 
recognize a primarily CTD Ser2P (save for Nrd1) (reviewed in Mischo and Proudfoot 
2013, Porrua and Libri 2015, Arndt and Reines 2015), but a recent addition to our 
understanding of this process is the role of Tyr1 of the CTD. Tyr1 phosphorylation is 
mostly similar to Ser2P in pattern when looking at gene-averaged ChIP profiles (Mayer 
et al. 2012), the difference being that Tyr1 phosphorylation decreases upstream of the 
pA site whereas Ser2 phosphorylation persists past the pA site. The phosphatase 
responsible for this change, Glc7, is part of the cleavage and polyadenylation factor 
(CPF) complex and acts at the polyadenylation site to cleave the mRNA and add a poly-
A tail post-dephosphorylation (Schreick et al. 2014). Another phosphatase, Rtr1, has 
also been described as having this activity, dephosphorylating both Ser5 and Tyr1 in 
vitro and providing a level of autoregulation at the mRNA level through REX 
exonuclease activity (Hsu et al. 2014, Hodko et al. 2016). The kinase responsible for 
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Tyr1P to begin with is not known in yeast, but in mammalian cells c-Abl has been 
identified early (Baskaran et al. 1993). 
With Tyr1 phosphorylation identified as modulating termination, it was found that 
termination factors Nrd1, Rtt103, and Pcf11 were primarily affected. The two factors 
Nrd1 and Rtt103 are quite different in form and function. Generally speaking, Nrd1 
associates with primarily CTD Ser5P, whereas Rtt103 associates primarily with CTD 
Ser2P, though this is not the only factor affecting termination pathway (Vasiljeva et al. 
2008, Gudipati et al. 2008, Heo et al. 2013).  The termination pathway chosen between 
these two factors involves Pcf11, which also has a CID that favors Ser2P but is 
stimulated once Ser5P is dephosphorylated (Lunde et al. 2010, Grzechnik et al. 2015). 
However, this is a simplified view of how these determine the fate of termination 
pathway, as CTD phosphorylation is dynamic and these termination factors bind to 
CTDs with a mix of Ser5 and Ser2 phosphorylation (in the case of Pcf11) or CTDs with 
all serine residues phosphorylated (in the case of Nrd1) (Barilla et al. 2001, Kubicek et 
al. 2012). In fact, Nrd1-dependent terminators appear in regions that overlap CTD Ser5 
and Ser2 phosphorylation, implying that several steps beyond detection of the CTD 
phosphostate are needed (Mayer et al. 2010, Tietjen et al. 2010). 
Nrd1 functions as part of the Nrd1-Nab3-Sen1 complex, composed of two RNA-
binding proteins (Nrd1 and Nab3) and a DNA/RNA helicase (Sen1) (Steinmetz et al. 
2001, Finkel et al. 2010, Jamonnak et al. 2011). Nrd1 and Nab3 recognize specific RNA 
sequences through their RNA recognition motif domains (RRMs), GUA[A/G] for Nrd1 
and UCUU for Nab3, which serve as terminators for snRNA and snoRNA transcripts 
(Steinmetz et al. 2001, Maris et al. 2005, Carroll et al. 2007). Sen1 then binds directly to 
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Nab3, which then enables NNS to bind to the exosome, a collection of RNases which 
degrades the nascent RNA (Conrad et al. 2000, Houseley et al. 2006). As the presence 
of the Nrd1 and Nab3 binding sites are found more often in AU-rich sequences or at 
sites with relatively short transcript length, it makes sense that the Nrd1 CID would be 
optimized for Ser5P binding (Kim et al. 2011, Porrua et al. 2012). The resulting 
transcripts, primarily cryptic unstable transcripts (CUTs) besides snRNAs and snoRNAs, 
require Sen1 to release the polymerase early (Porrua and Libri 2013) and the exosome 
to be recruited through the TRAMP complex (which additionally trims poly(A) tails of 
RNAs destined for the exosome), composed of Trf4, Air2, and Mtr4, which is done 
through the Nrd1 CID and Trf4’s Nrd1 interacting motif (which mimics CTD Ser5P) 
(Vasiljeva and Buratowski 2006, Tudek et al. 2014). Of note is that the relative number 
of molecules of Sen1 in the cell is extremely low (~125) compared to Nrd1 and Nab3, 
which may indicate that Sen1 might be a limiting factor in the process (Ghaemmaghami 
et al. 2003). 
While processing these non-coding RNAs requires the above complexes in yeast 
(exosome, TRAMP, and NNS), it is not clear that the homologs in human cells have all 
the same functions. The Sen1 homolog, Senataxin, has been implicated in 
neurodegenerative disorders such as ataxia and ALS (Moreira et al. 2004; Chen et al. 
2004) and also resolves RNA/DNA hybrids while also associating with the exosome as 
in yeast (Skourti-Stathaki et al. 2011; Richard et al. 2013). No known homologs of Nrd1 
or Nab3 exist in humans, though some human genes such as SCAF8 which encodes 
for a RNA-binding protein, have homology with Nrd1 while not showing function of 
processing snRNA genes (Yuryev et al. 1996, O’Reilly et al. 2014). In contrast, 
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mammalian snoRNA genes are found within introns, and a different complex not found 
in yeast called Integrator associates with the RNAP II CTD and enables transcription of 
snoRNA, similar to standard mRNA processing (Baillat et al. 2005, Richard and Kiss 
2006). A homolog of Nrd1, Seb1, has recently been found in S. pombe, however it does 
not function in NNS termination but instead associates with other 3’ processing factors 
and is involved in alternative poly-A site selection, as well as ncRNA binding in the 
process of heterochromatin reassembly (Marina et al. 2013, Lemay et al. 2016). 
Another alternative to NNS-mediated transcription termination is Poly-A Site 
(PAS)-dependent termination, which utilizes the cleavage and polyadenylation complex 
(CPAC) and is primarily associated with most protein-coding genes (reviewed in Mischo 
and Proudfoot 2013, Porrua and Libri 2015). Central to this is Pcf11, a CPAC 
component, which also determines the switch between NNS and PAS-dependent 
termination and is recruited both to 3’ ends of genes (as part of cleavage and 
polyadenylation factor IA) and to Nrd1-dependent terminators (Amrani et al. 1997, 
Grzechnik et al. 2015). The role of Pcf11 is more prominent in PAS-dependent 
termination, however; the N-terminal CID interacts preferentially with the CTD Ser2P 
(Noble et al. 2005, Lunde et al. 2010), followed by interaction with protein dimer Rna14-
Rna15 (binding to RNA) (Amrani et al. 1997, Noble et al. 2004, Paulson and Tong 
2012), and then two zinc finger domains mediate the interaction with Clp1 (Ghazy et al. 
2012, Yang et al. 2017). Together, these four components form cleavage and 
polyadenylation factor IA, and adding Hrp1, an hnRNPA/B family member which binds 
to RNA poly-A sequences, forms a complete cleavage and polyadenylation factor I 
(CFI) complex (Henry et al. 1996, Gaillard and Aguillera 2014). The RNA undergoes 
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endonucleolytic cleavage at the poly-A site, and a poly-A tail is added by poly-A 
polymerase Pap1; the Rat1 exonuclease completes the process by targeting the 5’ end 
of the transcript (see discussion on Rtt103) (Lingner et al. 1991, Brodsky and Silver 
2000, reviewed in Porrua and Libri 2015). 
Mutations in Pcf11 tend not to be tolerated by S. cerevisiae. The gene is 
essential, and mutations in either the CID or the domain that interacts with Clp1 are 
lethal (Sadowski et al. 2003). Specifically, mutants in the Clp1 interaction domain lead 
to defects in 3’ end processing and causes transcriptional readthrough (Noble et al. 
2007, Ghazy et al. 2012). However, should the interaction between Pcf11 and the 
RNAP II CTD be unimpeded, the conformational change of the CTD is transduced 
through to the CFI complex and leads to its dissociation; a mutation in the CID will lead 
to a failure to dismantle this complex (Zhang et al. 2005). Although the human version 
of Pcf11 primarily shares homology at the CID, and mutations in human Pcf11 also 
share defects in cleavage and termination (indicating functional conservation), human 
Pcf11 is otherwise twice as large and less well characterized (West and Proudfoot 
2008). 
In contrast to Nrd1, Rtt103 is much more conserved functionally from yeast to 
human. For it to function, the proteins Rat1 (a 5’ RNA exonuclease) and Rai1 
(decapping endonuclease) form a complex which then interacts with Rtt103, which has 
a CID that preferentially recognizes CTD Ser2P (Kim et al. 2004). The function of these 
three together form the basis for the “torpedo” model of termination, where the nuclease 
first processes the 5’-end of RNA after poly-A site-dependent cleavage (see section on 
Pcf11), and catches up with RNAP II before dissociating it from DNA (Connelly and 
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Manley 1988, West et al. 2004, Pearson and Moore 2013). Although it has been shown 
in vitro that Rat1 and Rai1 cannot elicit termination on their own (Dengl and Cramer 
2009), a more recent study has shown that stalled elongation complexes can in fact be 
dissociated using these two proteins, and that Rtt103 can recruit Rat1/Rai1 protein 
complex to the 3’ ends of genes (Lunde et al. 2010, Pearson and Moore 2013). Recent 
studies of the RNAP II CTD have confirmed that Rtt103 is not only preferentially 
associated with the Ser2P form (Suh et al. 2016), but also that Rtt103 is blocked by 
Tyr1 phosphorylation before the poly-A site (Mayer et al. 2012) and interacts with CTD 
Thr4P, possibly in the context of splicing (Suh et al. 2016, Harlen et al. 2016). Further 
connecting to Tyr1 phosphorylation of the CTD, it has been shown that Glc7, identified 
as a tyrosine phosphatase, is recruited to the 3’ ends of genes and enables the 
recruitment of Pcf11 and Rtt103, coupling Glc7 activity with the cleavage and 
polyadenylation factor machinery (Schreieck et al. 2014). 
The human homolog of Rat1 is Xrn2; it is also a 5’-3’ exoribonuclease and is 
associated with various cancers, most notably lung (Lu et al. 2010, Morales et al. 2014). 
Also, like Senataxin, the human homolog Xrn2 and the Rtt103 homolog Kub5-Hera 
have been shown to be involved in DNA damage response and double strand break 
repair, and specifically suppresses the formation of R-loops, which are persistent 
RNA:DNA hybrids that occur during transcription and are parts of the termination 
process (Skourti-Stathaki et al. 2011, Ni et al. 2011, Morales et al. 2014). The role of 
Rtt103 in DNA damage response is not clear, although it is known to be involved as 
deletions sensitize yeast to DNA damage, specifically double strand breaks, and is 
implicated in a DNA damage response involving RNAP II elongation (Srividya et al. 
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2012, Windsor et al. 2013). One possibility is that the ability of termination factors like 
Rtt103 to pause and disengage the polymerase is taken advantage of in this situation, 
which would enable the DNA damage response to work effectively (Srividya et al. 
2012). It is not surprising, then, that the phosphostate of the RNAP II CTD would be 
important if this was the case, and is in fact a plausible idea, since the Ser2 kinase Ctk1 
is necessary for DNA damage response in this exact case, with DNA damage leading to 
an increase in Ser2P globally (Ostapenko and Solomon, 2003). 
Concluding remarks 
With the advent of new tools and strategies to explore the different functions of 
the CTD, more of the gaps in the knowledge surrounding how the CTD is modified over 
the course of transcription and how it functions are being filled in. But differences 
between metazoans, or even between similar species such as budding and fission 
yeasts, have become apparent and raise more questions. For example, what is the 
significance of the involvement of the INO80 complex/Htz1 and Rtt103 for Thr4 
phosphorylation beyond budding yeast? The INO80 complex is evolutionarily conserved 
(Chen et al. 2011) and the Rtt103 homolog Kub5-Hera is well-studied (Morales et al. 
2014), but how their functions impact RNAP II activity vary, and not all of these 
functions are conserved between organisms. A stronger example of this divergence is 
evident with Tyr1. Beyond affecting termination factor recruitment, what aspects of Tyr1 
phosphorylation and Slt2 function are transferable to mammalian cells? Evidence that 
Slt2 is present with RNAP II on transcribed genes and homologs Erk1/2 are recruited to 
genes in a similar manner to Slt2 (Kim and Levin 2011, Mikula et al. 2016) has been 
reported, but might one of these kinases, or a related one, have Tyr1P activity? Future 
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studies will continue to describe the many intricacies of the CTD and discover new 
aspects of regulation, but now that the “orphans” are orphans no longer, continued 
comparison across organisms will prove enlightening. 
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Figure 1: Ser7 facilitates mRNA capping in S. pombe and snRNA processing in H. 
sapiens. (A) In S. pombe, Cdk9 (with cyclin partner Pcm1) binds to CTD Ser7P, and 
enables the recruitment of 5’ cap methyltransferase Pcm1 to a Ser5P CTD. Ser7 is 
phosphorylated by TFIIH subunit Cdk7/Mcs6, as well as by Bur1. (B) In H. sapiens, the 
12-subunit Integrator complex preferentially recognizes a Ser7P-Ser2P CTD at the 3’ 
end of snRNA genes.  Ser7P recruits RPAP2 to the CTD, which dephosphorylates 
Ser5P, and Integrator is able to recognize both the Ser7P-Ser2P CTD as well as the 
3’box of the snRNA, enabling cleavage and processing of the snRNA.  TFIIH subunit 
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Figure 2: Divergent functions of Thr4 between S. cerevisiae and H. sapiens. (A) In S. 
cerevisiae, Thr4P has been shown to recruit the multi-subunit Ino80 chromatin remodeling 
complex to certain classes of promoters (see text), which evicts the promoter-proximal H2A.Z 
(red)/H2B (blue) histone dimers. Upon eviction of these dimers and replacement with H2A/H2B 
dimers, transcription of these genes is enabled. (B) In H. sapiens, histone mRNA synthesis 
requires Thr4 for efficient 3’ processing. Thr4 is required for recruitment of stem-loop binding 
protein (SLBP) and CPSF100, required along with other canonical 3’ processing factors such 
as Symplekin and CPSF73, to replication-dependent histone genes. In S. cerevisiae, histone 
mRNA 3’ ends are formed identically to all other mRNAs, and evidence shows that instead 
Thr4P plays a role in post-transcriptional splicing and Rtt103 (and Rat1/Rai1) recruitment 
during termination. In H. sapiens, Cdk9 and Plk1/Plk3 have been shown to phosphorylate Thr4, 
the later perhaps specifically in M phase, and Thr4P is dephosphorylated by Fcp1. Neither the 











































Figure 3: Tyr1 has multiple functions across species. (A) At the 5’ ends of genes, Tyr1 in 
vertebrates is phosphorylated, likely by c-Abl, and Tyr1P is important for efficient turnover 
of 5’ upstream antisense RNAs (uaRNAs). Tyr1 phosphorylation also enhances stability 
and prevents degradation of the unstructured CTD by the 23S proteasome in vertebrate 
cells. In S. cerevisiae, this function has not been described, and Tyr1 phosphorylation (by 
Slt2 or other unidentified kinases) is associated with antitermination, as it prevents efficient 
binding of Nrd1 (in yeast) or Rtt103 (yeast and humans) to a Ser5P or Ser2P CTD, 
respectively. (B) At 3’ ends of genes, CTD Tyr1P is dephosphorylated by Glc7, a subunit of 
cleavage and polyadenylation factor (CPF). This leads to Ser2P-CTD recognition by Pcf11 
and Rtt103/Rat1/Rai1, which facilitates efficient termination. This function appears 
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The C-terminal domain (CTD) of the largest subunit of RNA polymerase II (RNAP 
II) consists of repeated YSPTSPS heptapeptides and connects transcription with 
cotranscriptional events. Threonine-4 (Thr4) of the CTD repeats has been shown to 
function in histone mRNA 3’-end processing in chicken cells and in transcriptional 
elongation in human cells. Here, we demonstrate that, in budding yeast, Thr4, although 
dispensable for growth in rich media, is essential in phosphate-depleted or galactose-
containing media. Thr4 is required to maintain repression of phosphate-regulated (PHO) 
genes under normal growth conditions and for full induction of PHO5 and the galactose-
induced GAL1 and GAL7 genes. We identify genetic links between Thr4 and the histone 
variant Htz1 and show that Thr4, as well as the Ino80 chromatin remodeler, is required 
for activation-associated eviction of Htz1 specifically from promoters of the Thr4-
dependent genes. Our study uncovers a connection between transcription and 
chromatin remodeling linked by Thr4 of the CTD. 
Introduction 
In eukaryotic cells, RNA polymerase II (RNAP II) transcribes all protein coding 
genes as well as a number of noncoding RNA genes, including those for most snRNAs 
and microRNAs. Expression of RNAP II-transcribed genes is highly regulated, ensuring 
that the timing of production, quantity, and structure of the RNAs generated is 
appropriate. Much of this regulation occurs on the genes themselves, whose 
accessibility is limited by nucleosomes that can form densely packed chromatin 
(reviewed in refs. 1 and 2). A significant amount of regulation, however, targets RNAP II 
itself. Specifically, the C-terminal domain (CTD) of Rpb1, the largest subunit of RNAP II, 
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is subject to a multitude of phosphorylation and dephosphorylation events that mark 
different steps of the RNAP II transcription cycle (recently reviewed in refs. 3–5). 
Although many of these modifications occur generally, some appear to play critical roles 
in expression of specific genes (6–8). The CTD consists of a tandemly repeated hepta-
peptide, whose consensus sequence, Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7, is 
conserved in yeast, which harbors 26 repeats, and vertebrates, with 52 repeats. The 
emerging picture places this unusual structure in a highly important role in coordinating 
transcription by RNAP II with other events in the generation and maturation of RNAs. 
Since its discovery, numerous studies have focused on the role of the entire CTD 
and the function of individual amino acids within its repeats. At promoters, the 
unphosphorylated CTD interacts directly with subunits of the Mediator complex (9), 
which is required for Mediator’s role in stimulating transcription (10). Additionally, early 
studies determined that the CTD is required for full activation by some promoter-bound 
activators (11–13) whereas it was later shown that the CTD can mediate the influence 
of activators on pre-mRNA processing (14–16). 
Several genome-wide analyses uncovered a pattern of CTD phosphorylation that 
occurs once RNAP II clears promoters (e.g., refs. 17 and 18). Phosphorylation of Ser5 
occurs near the 5’ end of genes where it enables recruitment of the capping machinery 
to the nascent pre-mRNA (19, 20), as well as recruitment of Set1, a COMPASS-
associated methyltransferase that modifies histone H3-Lys4 around the 5’ end of 
transcriptionally active genes (21, 22). Toward the 3’ end of genes, Ser5 
phosphorylation decreases, Ser2 phosphorylation increases, and CTD repeats that are 
dually phosphorylated on Ser5 and Ser2 can bind the Set2 methyltransferase, thereby 
55 
 
targeting histone H3 for trimethylation on Lys36 (23). Furthermore, Ser2 
phosphorylation functions in the recruitment of splicing, 3’ processing, and termination 
factors (reviewed in refs. 4 and 5). Like Ser5, Ser7 is phosphorylated near the beginning 
of the transcription cycle, and, although it is detected on both protein-coding and 
noncoding genes, mutation of Ser7 to Ala in human Rpb1 caused defects in expression 
specifically of snRNA genes (7). These studies demonstrate that the CTD not only 
participates in the production and processing of RNA but also leaves behind chromatin 
modifications that demarcate regions of transcriptionally active genes. 
We previously characterized the role of threonine-4 (Thr4) of the CTD repeats by 
generating chicken DT40 cells that express a mutant form of Rpb1 in which each Thr4 
was replaced with Val (8). Cells expressing the Thr-Val (T4V) form of the CTD were not 
able to survive past 24 h, likely due to defects that were detected in 3’-end processing 
specifically of histone pre-mRNAs. In metazoans, histone mRNA 3’ processing involves 
a mechanism that is distinct from the typical polyadenylation of other pre-mRNAs, 
whose processing and expression were not affected by the Thr4 mutation. In another 
study, ChIP-seq analysis determined that Thr4 phosphorylation increases toward the 3’ 
end of RNAP II-transcribed genes and that Thr-to-Ala mutation caused defects in 
transcription elongation in a human cell line (24). In budding yeast, histone pre-mRNAs 
are not processed by a distinct mechanism, leading to the question of whether Thr4 
plays gene-specific and/or general roles in transcription in that organism. Thr4 mutation 
in fission yeast was shown to be without effect on growth (25, 26). 
Here, we address the role of Thr4 in Saccharomyces cerevisiae by characterizing 
a strain that expresses a T4V mutant form of Rpb1. The mutant strain is viable and 
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shows no general transcriptional defect in normal growth conditions but is unable to 
grow in low phosphate or galactose-containing medium. Linking Thr4 with phosphate 
and galactose metabolism, we found that T4V cells are unable to fully repress 
phosphate-regulated (PHO) genes under normal growth conditions and to fully activate 
PHO5 and the galactose-inducible GAL1 and GAL7 genes under their respective 
inducing conditions. We identify genetic links between T4V and genes encoding the 
SWR1 and INO80 chromatin remodeling complex subunits, as well as the gene 
encoding the target of these complexes, the histone variant Htz1. Connecting our 
observations, we demonstrate that eviction of Htz1 from promoter-proximal 
nucleosomes, a process associated with gene activation, is defective in T4V cells, 
specifically for the genes requiring Thr4 for activation, and we implicate the Ino80 
complex in Thr4-mediated loss of Htz1 from these genes. Our study, therefore, links 
Thr4 of the yeast CTD with promoter-associated chromatin remodeling necessary for 
control of activated transcription. 
Results 
Thr4 Is Phosphorylated on RNAP II Transcribed Genes but Is Not Essential for 
Viability in Rich Medium 
In our previous study, we determined that phosphorylated Thr4 (P-Thr4) is 
present on Rpb1 in chicken and human cells, and in budding yeast (8). To characterize 
Thr4 phosphorylation in yeast, we first conducted chromatin fractionation using yeast 
extracts and found by Western blot (WB) with a P-Thr4 specific antibody that Thr4 is 
phosphorylated specifically on chromatin-associated RNAP II (Fig. 1A), suggesting that 
Thr4 functions during transcription. To explore this possibility, we constructed a yeast 
57 
 
strain in which Thr4 on each repeat of the CTD was replaced by Val, analogous to what 
was done in DT40 cells (8). This strain, named T4V, expresses only Rpb1 containing 24 
repeats of the sequence YSPVSPS. In addition to replacing Thr with Val, this mutant 
also eliminated the naturally occurring variation found in some repeats of the CTD (27). 
To account for any effects that might result from this loss of nonconsensus residues 
instead of the Thr-Val switch, we constructed a control strain that expressed an Rpb1 
with 26 consensus CTD repeats, named CONS. Fig. 1B confirms by WB that Thr4 was 
phosphorylated in the WT and CONS strains, but not in the T4V strain, and that Rpb1 
levels in T4V, CONS, and WT strains were equivalent (SI Appendix, Fig. S5A). 
Comparison of growth of the three strains showed that T4V displayed a transient and 
modest growth defect, compared with WT and CONS, on both rich and synthetic 
complete (SC) medium and that this defect was exacerbated at low temperatures 
(18 °C) (Fig. 1C). Chromatin immunoprecipitation (ChIP) analysis showed that P-Thr4 
was detected on constitutively active and activated inducible genes and that the T4V 
mutation did not significantly affect RNAP II levels on constitutive genes (SI Appendix, 
Fig. S1 A–D). 
Thr4 Is Required for Repression of Phosphate-Regulated Genes in Normal 
Medium 
Our observation that Thr4 is not essential for growth indicates that it is not 
generally required for RNAP II transcription. However, to determine whether Thr4 is 
involved in transcription of specific genes, we first performed global mRNA sequencing 
(RNA-seq) in WT and T4V strains grown in SC medium. A summary of the most 
significantly up- and down-regulated genes is shown in Fig. 2A, and the full results are 
58 
 
in Dataset S1. Seventeen genes displayed an average increased expression of at least 
threefold (log2 > ∼1.6) whereas nine genes showed an average drop in expression of at 
least threefold (log2 < ∼1.6). A diagram of WT and T4V RNA-seq read distributions over 
the chromosomal loci for up-regulated genes PHO84 (with unaffected flanking genes) 
and PHO5, and down-regulated gene PTC2, is shown in Fig. 2B. Interestingly, 
approximately half of the up-regulated genes are involved in phosphate metabolism 
(Fig. 2A, indicated by asterisks). Specifically, these genes, hereafter referred to as PHO 
genes, are also up-regulated under growth conditions of low inorganic phosphate (Pi) 
levels (28). RT-PCR analysis on a subset of the regulated genes validated the RNA-seq 
results and confirmed that the T4V mutation resulted in up-regulation of PHO genes (SI 
Appendix, Fig. S2). 
To determine whether these changes in gene expression were specific to the 
T4V mutation and not due to the loss of nonconsensus CTD repeats, we performed an 
additional RNA-seq analysis comparing mRNAs from CONS and WT strains. This 
analysis showed no similarity with the T4V vs. WT RNA-seq analysis (SI Appendix, Fig. 
S3). Although PHO84 mRNA levels were approximately threefold higher in CONS than 
in WT (log2 of 1.68), this increase was dramatically less than in T4V (>1,000-fold, log2 
of 10.8), and no derepression of other PHO genes was observed in the CONS strain 
(Fig. 2A and Dataset S2). Some PHO-regulated genes, however, also appeared up-
regulated in the CONS strain in the RT-PCR validation (SI Appendix, Fig. S2). An 
explanation for this apparent discrepancy stems from the fact that the RT-PCR analysis 
was performed with random-primed RNA, which detected polyA− as well polyA+ 
transcripts whereas the RNA-seq analysis detected only polyA+ RNAs. Thus, a 
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parsimonious interpretation of these results is that loss of nonconsensus CTD residues 
resulted in production of polyA− transcripts, which could be sense and/or antisense, 
from some PHO genes, whereas mutation specifically of Thr4 led to up-regulation of 
polyA+ sense transcripts from all PHO genes analyzed. Furthermore, RNA-seq of a 
strain expressing Rpb1 with a mutant CTD composed entirely of otherwise consensus 
repeats in which all Tyr1 residues were changed to Phe (Y1F) revealed no up-regulation 
of the PHO genes. Our results, therefore, demonstrate that the CTD is involved in 
repressing PHO gene transcription and that Thr4 functions specifically in preventing the 
production of polyadenylated PHO mRNAs during normal growth. 
To extend the above results, we examined growth of the T4V strain in low Pi 
medium. Strikingly, whereas WT and CONS strains grew normally on this medium, T4V 
was inviable (Fig. 2C). T4V sensitivity to low Pi medium was observed in both S288C 
and W303 background strains. Although both the RNA-seq and RT-PCR analyses 
showed significant derepression of PHO-regulated genes in the T4V strain, derepressed 
transcription levels for PHO5 and PHO84 were still significantly lower than observed 
during normal induction of these genes in low Pi conditions (Fig. 2D). Our observations, 
therefore, indicate that, although Thr4 is required for normal expression of only a small 
number of genes under normal growth conditions, it is necessary for repression of PHO-
regulated genes and plays an essential role in the cellular response to low phosphate 
levels. 




To identify pathways that mediate the effects of Thr4 on growth and transcription, 
we carried out genome-scale yeast genetic interaction assays [synthetic genetic array 
(SGA)] (29) with the T4V and CONS strains. Genes whose deletion in combination with 
the T4V mutation (but not with the CONS mutation) resulted in the most dramatic 
growth defect in both of two independent SGA analyses are listed in SI Appendix, Fig. 
S4, and the subset of these genes that is involved in transcription and chromatin 
regulation is indicated in Fig. 3A. Notably, several components of the SWR1 chromatin 
remodeling complex were among the strongest genetic interactions with the T4V 
mutation, which we confirmed by comparing the growth of independently derived 
double-mutant strains with single-mutant strains (Fig. 3B). The SWR1 complex replaces 
conventional histone H2A with the variant Htz1 (also known as H2A.Z) in nucleosomes 
(30–32), specifically those associated with promoters of transcriptionally inactive genes 
(33–35). Additionally, the gene encoding Ies2, a subunit of another chromatin 
remodeling complex, the INO80 complex (INO80c), showed a strong genetic interaction 
with T4V (Fig. 3A) (most other genes encoding INO80c subunits are essential and were 
therefore not represented in the screen). INO80c can exchange Htz1/H2B dimers for 
H2A/H2B in in vitro assays and is required for normal localization of Htz1 across the 
genome, suggesting that it functions in cells to remove Htz1 from activated promoters 
(36). 
The HTZ1 gene was also a strong hit in the SGA screen. Consistent with this 
genetic interaction, HTZ1 and the T4V mutation showed a synthetic lethal interaction in 
multiple independent tetrad dissection analyses (Fig. 3C). T4V spores derived from 
HTZ1/htz1Δ WT-RPB1/T4V double heterozygotes displayed a more severe growth 
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defect than normal after dissection (compare Fig. 3C, Upper with Fig. 1C; and see also 
Fig. 5B) although, like other T4V strains, the defect was transient and T4V approached 
WT growth after ∼48 h (Fig. 3C, Lower). Additionally, attempts to delete HTZ1 in a 
haploid T4V strain by homologous recombination produced no viable transformants. In 
another approach, we deleted HTZ1 in WT, CONS, or T4V strains harboring an HTZ1 
expression plasmid (with a URA3 marker) and then eliminated the plasmid by growth on 
5-FOA. Only the T4V htz1Δ background showed no growth on 5-FOA (Fig. 3D), 
supporting the synthetic genetic interaction between HTZ1 and T4V. These results 
together strongly implicate Thr4 in Htz1-related pathways. 
Thr4 Is Required for Expression of PHO5, GAL1, and GAL7 and for Eviction of 
Htz1 from Their Promoters During Induction 
Htz1 is typically found within the two nucleosomes that flank the nucleosome-free 
region at RNAP II promoters (34, 37), and, although it is not required for maintaining a 
repressed state, its removal from these nucleosomes stimulates gene activation (33, 
35). Correspondingly, genomic analyses localized Htz1 primarily at repressed gene 
promoters, and its occupancy is inversely proportional to transcription levels (33, 35, 37, 
38). Relating Htz1 function with our observed role for Thr4 in PHO gene regulation, a 
previous study (39) demonstrated that HTZ1 acts synthetically with genes encoding the 
SWI/SNF chromatin-remodeling complex to activate expression of PHO5, which 
encodes the cell’s major acid phosphatase (40). We compared growth of htz1∆ and T4V 
cells on low Pi medium and found that the two strains displayed strong growth defects, 
indicating that both Thr4 and Htz1 indeed play critical roles in the PHO pathway (Fig. 
4A). We then determined whether Thr4 and Htz1 are needed for expression of genes 
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induced during low Pi conditions and found that both T4V and htz1∆ strains showed 
reduced expression of PHO5 whereas induction of another PHO gene, PHO84, was not 
affected (Fig. 4B). 
We also tested for growth defects on other media in which gene induction is 
necessary for growth. We found that T4V was also highly sensitive to medium 
containing galactose as the sole carbon source but grew normally on amino acid-
depleted or high osmolarity media (Fig. 4A). Low Pi and galactose sensitivity was 
specific to the T4V mutation because the CONS and strain did not show specific growth 
defects on these media (Fig. 4A). Galactose sensitivity correlated with reduced 
expression of the galactose-induced GAL1 and GAL7 genes in T4V (Fig. 4B) whereas 
expression of the amino acid starvation-induced ARG1 and high osmolarity-induced 
STL1 genes was not affected. Notably, a previously described strain expressing Rpb1 
with a CTD truncated to ∼13 repeats showed normal activation of the GAL1 promoter 
(11), further demonstrating that the observed defects are specific for the Thr4 mutation. 
In all cases, reduced transcription of genes in T4V correlated with less RNAP II 
recruited to the genes’ promoters, as determined by ChIP analysis (SI Appendix, Fig. 
S1D). The htz1∆ strain also grew normally on amino acid-depleted and high osmolarity 
media, but, although Htz1 is known to play a role in activation of GAL1 (39, 41, 42), our 
htz1∆ strain (and several additional clones derived from the W303 parental strain) failed 
to display a significant growth defect on galactose (Fig. 4A) (see discussion). Taken 
together, our results indicate that Thr4 is required for full induction of a subset of 




Eviction of Htz1 from promoter-associated nucleosomes is thought to stimulate 
gene activation by exposing promoter DNA (35). To address whether impaired 
activation of PHO5, GAL1, and GAL7 in T4V cells reflected defective eviction of Htz1 
from their respective promoters, we used strains expressing Htz1 as a 6x-HA epitope-
tagged derivative (SI Appendix, Fig. S5A) and performed ChIP experiments with an HA 
antibody. Fig. 4C shows that, in WT cells, induction of PHO5, PHO84, GAL1, and GAL7 
resulted in a significant loss of Htz1 from their respective promoter regions, confirming 
that Htz1 eviction corresponds with activation of these genes. Consistent with our gene-
expression analysis, the T4V mutation effectively abolished Htz1 loss from the PHO5, 
GAL1, and GAL7 promoters during their induction, but not from PHO84 (Fig. 4C). 
Defective Htz1 eviction on these genes is specific to the CTD Thr4 mutation because 
altering the CTD to all consensus repeats (CONS) did not affect Htz1 loss on the GAL1 
promoter (SI Appendix, Fig. S5B). At the uninduced PHO5 and PHO84 promoters, less 
Htz1 was detected in T4V cells than in WT (Fig. 4C), probably caused by nucleosome 
loss coinciding with derepression of these genes due to the Thr4 mutation (see 
discussion). Despite the lower levels of Htz1 in the T4V mutant, significant Htz1 eviction 
was observed for PHO84, but not for PHO5. These observations strongly link Htz1 
promoter dynamics to Thr4 and indicate that Thr4 is required for Htz1 eviction from 
some inducible genes, thereby enabling their full induction. 
INO80c Functions in Thr4-Mediated Stimulation of Htz1 Eviction 
We next examined whether Thr4 stimulates Htz1 loss from specific activated 
promoters through an INO80c-dependent mechanism. Indeed, Htz1 ChIP analysis 
showed that Htz1 loss from promoters of PHO5, GAL1, and GAL7 during induction was 
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defective in cells expressing a nonfunctional, truncated version of the Ino80 ATPase 
subunit of the complex (ino80Δ900) (Fig. 4C). Consistent with previous observations 
that Ino80 plays a general role in regulating Htz1 occupancy on the genome (36), 
ino80Δ900 cells showed reduced Htz1 occupancy on both PHO5 and PHO84 promoters 
in normal growth conditions (Fig. 4C). During induction of these genes, however, loss of 
Ino80 resulted in impaired Htz1 eviction for PHO5 but not PHO84, paralleling the results 
seen with the T4V mutation (Fig. 4C). In all cases, impaired Htz1 loss from promoters 
resulted in reduced induction of the respective genes (Fig. 5A). These observations, 
therefore, implicate both Thr4 and Ino80 in clearing Htz1 from a specific set of induced 
promoters and suggest that Ino80 mediates the effects of Thr4 on induction of these 
genes (i.e., genes showing a requirement for Thr4 for induction are genes that show 
Ino80-dependence for Htz1 eviction). In support of this notion, in addition to the genetic 
interaction we detected between T4V and IES2 in the SGA screen (Fig. 3A), we 
detected a negative synthetic genetic interaction between INO80 and the T4V mutation 
(Fig. 5B). Furthermore, like T4V, cells lacking Ino80 were unable to grow on low Pi 
medium, were highly sensitive to galactose, but were essentially unaffected by amino 
acid depletion or high osmolarity (Fig. 5C). Therefore, our data implicate Ino80 in Thr4-
stimulated loss of Htz1 from PHO5, GAL1, and GAL7 promoters, pointing to an 
unexpected role for the CTD in chromatin remodeling. 
Discussion 
Here, we have provided evidence that Thr4 of the CTD plays a critical but 
selective role in transcription in budding yeast. Like our previous analysis of Thr4 
function in chicken cells (8), we found that this highly conserved CTD residue does not 
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play a general role in transcription, but functions in expression of specific genes. Thr4 is 
required for both repression of PHO genes and for full activation of a subset of inducible 
genes, including PHO5, GAL1, and GAL7. Although it is likely that Thr4 maintains PHO 
gene repression by regulating chromatin structure, we found that its role in activation 
involves stimulating the eviction of Htz1 specifically from promoters of the Thr4-sensitive 
genes. To carry out this function, we provided evidence that Thr4 recruits or stimulates 
INO80c, whose chromatin remodeling activity acts to remove Htz1 from those 
promoters. Below, we discuss these previously unidentified functions of the CTD. 
Our data implicate Thr4 in both repression and activation of specific genes, and 
chromatin remodeling appears to be at play in both cases. Repression of PHO-
regulated genes is accomplished by blocking access of the basic helix–loop–helix 
transcription factor Pho4 to its recognition elements upstream of the PHO genes, by 
keeping it out of the nucleus and through interference with positioned nucleosomes on 
its binding sites (43). Consequently, disruption of chromatin structure at PHO genes 
leads to derepression. For example, in the absence of Set1, loss of H3K4 methylation 
causes reduced nucleosome occupancy around the PHO5 promoter, and, as a result, 
PHO5 becomes derepressed (44). Under repressive conditions, Cbf1, another basic 
helix–loop–helix protein, binds chromatin at many of the same sites that become bound 
by Pho4 under conditions of low Pi (45). Cbf1 is required for normal nucleosomal 
positioning (46), and, in its absence, PHO genes become derepressed, even under 
normal Pi conditions, when most Pho4 is cytoplasmic (43). Interestingly, there is a high 
degree of overlap between genes that we found are up-regulated in T4V with genes up-
regulated in CBF1-deleted cells (43), suggesting that a similar defect in nucleosomal 
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arrangement occurs in T4V cells. Indeed, the reduced levels of Htz1 at the PHO5 and 
PHO84 promoters that we detected in T4V cells in noninducing conditions likely reflect 
reduced nucleosome occupancy at these derepressed genes. It is likely, then, that Thr4 
contributes to maintaining the nucleosomal structure necessary for repression of PHO 
genes. 
Induction of PHO5 and GAL1, two of the Thr4-sensitive genes we identified, has 
been studied in some detail, and Htz1 is known to play a role in this process. Although 
Htz1 is evicted from the GAL1 promoter upon induction (39, 41) and is quickly 
redeposited upon returning to a repressed state (47), its effects are on GAL1 activation, 
not repression. Cells lacking HTZ1 show reduced recruitment of TBP, RNAP II, 
Mediator, SAGA, and Swi/Snf, with reduced GAL1 expression as a consequence (39, 
41, 42, 47). The effect is transient (47), however, and, in some cases, RNAP II is 
efficiently recruited to the induced GAL1 promoter, and GAL1 expression occurs in the 
absence of Htz1 (our results and refs. 39 and 48), indicating that other pathways can 
sometimes compensate for the lack of Htz1. Htz1 eviction also occurs at the PHO5 
promoter upon its induction (39, 49). Nucleosome disassembly at the PHO5 promoter 
was shown to be rate-limiting for its expression (50), and efficient PHO5 induction is 
dependent on Htz1 (our results and ref. 39). We have now shown that Thr4 is required 
for eviction of Htz1 from GAL1 and PHO5, as well as GAL7 promoters. The 
consequences of the T4V mutation on expression of these genes and growth on low Pi 
and galactose-containing media are more severe than in htz1∆ cells, indicating that, 
beyond promoting Htz1 eviction, Thr4 likely stimulates expression through additional 
pathways. Nonetheless, our data, supported by genetic interactions between T4V and 
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HTZ1 and its regulators, connect transcription to chromatin remodeling by stimulating 
Thr4-dependent Htz1 eviction. 
Our data also implicate INO80c in Thr4 function. In addition to roles in double-
strand break repair and stalled replication fork recovery (51), INO80c is required for full 
induction of a number of genes, including reporter genes containing upstream activation 
sequences of the PHO5 or GAL1 promoters (52, 53). INO80c associates with many 
RNAP II promoters and is recruited to genes when they are activated (54, 55), including 
PHO5, where it was shown to be required for nucleosome remodeling and gene 
induction (52). In the absence of Ino80, Htz1 localization across the genome is 
perturbed, with increased occupancy at some loci and reduced occupancy at others, 
thereby linking INO80c with Htz1 dynamics (36). More specifically, Ino80 is required for 
Htz1 eviction from the KAR4 promoter during induction, demonstrating that it can 
function in clearing promoter-proximal nucleosomes of Htz1 coincident with gene 
activation (36). Indeed, we have now shown that additional genes, specifically those 
that are sensitive to the T4V mutation (i.e., PHO5, GAL1, and GAL7), also require Ino80 
for efficient Htz1 loss during their activation. Based on our findings, we expect that other 
genes found to be dependent on Ino80 for Htz1 eviction will also show Thr4 sensitivity. 
We have presented several lines of evidence linking Thr4 with Ino80 function. 
Based on these connections, we propose a model (Fig. 6) in which, upon activation, a 
recruited molecule of RNAP II triggers eviction of Htz1 from promoter-proximal 
nucleosomes by stimulating the INO80 complex, or facilitating its recruitment, to newly 
activated promoters, in a manner dependent on Thr4 or its phosphorylation. We were 
unable to detect an Ino80–Rpb1 interaction by coimmunoprecipitation, suggesting that 
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recruitment or stimulation of INO80c by Thr4 is transient and/or mediated by other 
factors. However, failure to detect such an interaction is not surprising as many known 
CTD interactions are not detectable in this type of assay. For example, capping 
enzymes, polyadenylation factors, and the CTD kinases Ctk1 and Kin28 were not 
detected in a tandem-affinity purification of Rpb1 even though they are all well-
characterized CTD binding proteins (56). Importantly, transcription and RNAP II have 
been shown to be important for promoter-proximal nucleosome eviction (57). We now 
implicate Thr4 and INO80c in this process, which we propose facilitates further 
recruitment of additional RNAP II molecules. In vitro studies showed that INO80c evicts 
Htz1/H2B dimers from nucleosomal octamers and that, in some cases, eviction was part 
of an INO80c-dependent Htz1/H2B exchange for H2A/H2B (36) whereas, in another in 
vitro study, INO80c was not able to replace Htz1/H2B dimers with H2A/H2B dimers in 
nucleosomal arrays (58). In our model, however, we suggest that Thr4-mediated 
recruitment or stimulation of INO80c at specific promoters causes a loss of Htz1 that 
destabilizes promoter-proximal nucleosomes, thereby increasing accessibility to 
promoter DNA and facilitating further rounds of RNAP II recruitment and increased 
transcription (33, 35). Consequently, H2A-containing nucleosomes (which presumably 
form at promoters in the absence of Htz1) are not efficiently destabilized by INO80c, 
resulting in reduced gene activation. 
Defects in repression or activation that result from the T4V mutant CTD might 
arise from an inability to phosphorylate the mutated Thr residues. Genomic ChIP 
analysis determined that the average Thr4 phosphorylation pattern in human cells 
increases toward the 3’ end of genes (24). In yeast, a genomic ChIP (59), as well as our 
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ChIP analysis of individual genes, showed that most Thr4 phosphorylation is detected 
on Rpb1 associated with the middle portion of genes, with only low levels detected at 
promoters. This distribution might indicate that the Thr residue itself is important for 
promoter-specific functions, including those we report in this study. 
A recent study examined the transcriptomes of fission yeast strains harboring a 
variety of CTD substitutions (25). Consistent with our findings, mutation of Thr4 (to Ala; 
T4A) in that study affected expression of only a small number of genes, including 
orthologs of PHO5 and PHO84. However, whereas our T4V mutation resulted in 
derepression of these genes, in fission yeast expressing the T4A mutant, expression of 
the orthologous genes was significantly decreased. The different effect of Thr4 mutation 
might reflect differences between the two species. For example, Ser2 has been shown 
to be required for viability in S. cerevisiae but not in Schizosaccharomyces pombe 
during normal growth (26, 60). Differences between the CTD constructs could also 
contribute (e.g., T4A and 14 consensus heptads in ref. 29, compared with T4V and 24 
heptads in our study). Nonetheless, the fact that PHO5 and PHO84 (and orthologs) are 
among only a small number of genes whose expression relies on Thr4 in both budding 
and fission yeast strains strongly points to conserved roles for this CTD residue in 
regulating transcription of PHO genes. 
An interesting question is whether our findings on Thr4 function extend to 
metazoan organisms. As mentioned above, two studies have characterized the role of 
Thr4 and its phosphorylation in vertebrate species, in which it plays functions necessary 
for viability (8, 24). Furthermore, INO80c functions in promoting eviction of transcription 
start site-associated nucleosomes containing the mammalian Htz1 ortholog H2A.Z 
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during gene activation in mouse embryonic stem cells during differentiation, indicating 
that the same basic INO80c-mediated mechanism is at play throughout eukaryotes (61). 
It remains to be seen whether the role we uncovered for Thr4 in mediating this 
mechanism in yeast is conserved in higher species. In any event, our results show that 
Thr4 of the yeast CTD plays an important role in coupling transcription with promoter-
associated nucleosomal remodeling, providing yet another function for the 
multifunctional CTD. 
Materials and Methods 
A detailed description of yeast strain construction and growth conditions, ChIP, RNA 
and protein analyses, and RNA sequencing can be found in SI Appendix, SI Materials 
and Methods. Briefly, T4V and CONS strains were constructed by homologous 
recombination in yeast strains using CTD constructs prepared for our previous study 
(8). SGA analysis, comparing CONS and T4V strain genetic interactions, was as 
previously described (62). RT-PCR analyses were performed with random-primed total 
RNA for cDNA synthesis whereas RNA-seq experiments used polyA+ RNA. Primer 
sequences used for cloning, ChIP, and RT-PCR are available upon request. 
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Figure 1: Thr4 of the yeast CTD is phosphorylated on chromatin-
associated RNAP II and is not essential for viability. (A) Chromatin 
fractionation of yeast extract followed by Western blot analysis with 
an RNAP II antibody (Rpb1), an antibody that recognizes 
phosphorylated Thr4 on CTD repeats (T4p) (8), and a GAPDH 
antibody. (B) Western blot analysis of yeast extracts derived from 
WT, CONS, or T4V strains analyzed with the same antibodies as in 
A. The asterisk (*) indicates a nonspecific cross-reacting band 
detected at longer exposures. (C) Yeast spot assay comparing 
growth of WT, CONS, and T4V strains, with serial fivefold dilutions, 
on rich or synthetic complete (SC) medium at 30 °C, or on SC 
medium at indicated temperature, for indicated number of days.
Figure 2
78
Figure 2: Thr4 is required to maintain repression of PHO genes under normal 
growth conditions. (A) Summary of most significantly up- and down-regulated 
genes from RNA-seq analysis performed in WT and T4V strains grown in SC 
medium. Average change in expression of genes (log2) in T4V over WT strains 
and P value (Fisher’s exact test) were determined from two sets of data and are 
indicated here (refer to Dataset S1 for a complete list and details). Corresponding 
log2 and P values from the WT versus CONS RNA-seq analysis (Dataset S2) are 
also shown. Genes previously demonstrated to be up-regulated during conditions 
of low Pi (28) are indicated (*). P values that are beyond the limit of our analysis 
are indicated with double asterisk (**). NA, genes whose expression was not 
detectable in the sample. (B) Read distributions from the WT versus CONS RNA-
seq analysis for selected genes including PHO84 (with flanking genes shown), 
PHO5, and PTC2. (C) Spot assay comparing growth of indicated strains and serial 
fivefold dilutions on normal or low Pi medium. (D) RT-PCR analysis of PHO5 and 
PHO84 RNA levels in SC or low Pi media in WT or htz1∆ strains.
Figure 3
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Figure 3: Thr4 is linked genetically to Htz1 and its regulators. (A) List of genes 
showing synthetic genetic interaction with T4V mutation in two SGA screens. 
Genes displaying strongest interactions and involved in RNAP II transcription or 
chromatin regulation are shown (refer to SI Appendix, Fig. S2 for a complete list). 
(B) Confirmation of genetic interaction between T4V and SWR1 and SWC5 
components of SWR1 complex. Strains of indicated genotypes were generated by 
recombinant transformation and growth compared by spot assay on SC medium 
with serial fivefold dilutions. YBR184W showed no interaction with T4V in SGA 
screen and serves as a control. (C) Tetrad dissection analyses demonstrating 
synthetic lethal phenotype between T4V and HTZ1. Growth after 24 h is shown. 
After 48 h, colonies were streaked onto rich-medium plates, and growth is shown 
after additional 48 h. Genotype of inviable double mutant was inferred based on 
expected segregation pattern. (D) WT, T4V, and CONS strains were transformed 
with plasmid (pHTZ1 CEN URA3), and then endogenous HTZ1 was deleted by 
homologous recombination. Original and product strains were spotted on media 
shown, including 5-fluoroorotic acid (5-FOA), which allows growth only in the 
absence of URA3 expression (i.e., if the plasmid is lost).
Figure 4
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Figure 4: Thr4 is required for full expression and Htz1 eviction from 
promoters of specific genes. (A) Spot assay comparing growth of indicated 
strains and serial fivefold dilutions on indicated medium. Amino acid 
starvation medium was previously described (63). (B) RT-PCR analysis of 
mRNA levels of indicated genes under the respective inducing conditions, 
with PMA1 levels analyzed as control, grown in SC medium. Data are 
represented as mean ± SD of three independent experiments. (C) ChIP
analysis of Htz1-6HA occupancy at promoter regions of indicated genes, 
uninduced or induced as indicated, in WT, T4V, and ino80∆ strains. Data are 
represented as mean ± SD of three independent experiments, and P values 




Figure 5: Evidence that Thr4 dependence is linked to the INO80 complex. (A) RT-
PCR analysis of mRNA levels of indicated genes under respective induced 
conditions in indicated strains. Data are represented as mean ± SD of three 
independent experiments. (B) Tetrad dissection analyses demonstrating negative 
synthetic genetic interaction between T4V and INO80. Growth after 48 h is shown. 




Figure 6: Model indicating role for Thr4 of yeast CTD repeats in promoting Htz1 
eviction. On repressed genes, promoter-proximal nucleosomes contain Htz1/H2B 
dimers (depicted as encircled Z and B). During activation, an initially recruited RNAP 
II molecule stimulates INO80 activity or recruitment through Thr4 or Thr4 
phosphorylation, thereby enabling INO80-mediated eviction of Htz1/H2B from 
nucleosomes. Htz1 eviction destabilizes nucleosomes, facilitating their loss and 
increasing DNA access for further rounds of transcription. When transcription ends, in 
the absence of Thr4, INO80 no longer acts, and Htz1/H2B is redeposited at promoter-
proximal nucleosomes by the SWR1 complex.
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MATERIALS AND METHODS  
Yeast strains and growth media.  
Yeast strains used are listed in Table S3. T4V and CONS strains were constructed by PCR 
amplification of corresponding CTDs generated in preparation for our previous study (1), followed 
by transformation into haploid S288C or W303 strains. WT, CONS, and T4V strains were marked 
with NAT-MX cassette 3′ of the RPO21 gene. Low Pi medium was prepared by dissolving 10 g/L 
yeast extract, 20 g/L peptone and 2.45 g/L magnesium sulfate in water, then adding drop-wise 8 
mL/L ammonium hydroxide while mixing vigorously. The medium was allowed to sit for several 
hours on a bench to allow salts to precipitate, which were then filtered twice by vacuum filtration 
(0.22 μm). Glucose was then added to 2% (w/v), the pH was adjusted to ~7.0 with hydrochloric 
acid, and the medium was autoclaved. For solid medium, agar was added after pH adjustment. A 
yeast strain lacking PHO4 was unable to grow specifically on the low Pi medium confirming it 
was successfully depleted of phosphate (Figure 2C). For liquid growth on low Pi medium, samples 
that had grown overnight in SC medium were washed then placed in low Pi medium for 5-6 hours 
before analysis. For liquid growth in galactose medium, samples were first grown in SC plus 
raffinose (2% w/v), then galactose was added to 5% (w/v) for one hour before samples were 
analyzed. SGA screen, yeast spot assays and media used were as previously described  (2, 3).  
ChIP, RNA and protein analyses.  
Chromatin fractionation was performed as previously described (4)  in strain W303a. For 
ChIP analyses, 50-mL cultures were grown and cells were lysed by bead-beating three times for 
one min each with one min in between in a cold room, but, otherwise, samples were processed and 
analyzed, and data quantified, as previously described (3). Western blot analyses and 
semiquantitative PCR were as previously described (2, 3, 5). Random hexamer oligonucleotides 
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were used with total RNA for the RT-PCR analyses. Where statistical analysis was performed for 
ChIP, a two-tailed Student’s t-test was used, with P-values indicated above bars in the graph. Error 
bars in graphs represent standard deviations of at least three experiments. Antibodies used for ChIP 
and western blotting were HA (abm), GAPDH (Sigma), T4p (Novus), and Rpb1 (y-80; Santa Cruz). 
Primer sequences used for cloning, ChIP and RT-PCR analyses are available upon request.  
RNA sequencing.  
  For RNA sequencing analyses, the integrity of total RNA was measured by Agilent  
Bioanalyzer. RNA samples with an integrity number >8.0 were used for further processing. For 
T4V vs WT samples, total RNA was subjected to 2 rounds of poly(A) selection using oligo-dT 
magnetic beads (NEB) followed by fragmentation using Ambion’s RNA fragmentation kit at 70°C 
for 5 min. Fragmented RNA was purified by ethanol precipitation followed by dephosphorylation 
using recombinant shrimp alkaline phosphatase (NEB) and then phosphorylation using T4 kinase 
(NEB). Phosphorylated RNA was then purified by RNeasy kit  
(Qiagen) and was sequentially ligated to a 5′-adenylated 3′ adapter 
(5′/5rApp/TGGAATTCTCGGGTGCCAAGG/3ddC/) with the truncated T4 RNA ligase 2 (NEB) 
and to a 5′ adapter (5′-GUUCAGAGUUCUACAGUCCGACGAUC) with T4 RNA ligase 1  
(NEB). The resultant RNA was reverse-transcribed to cDNA with Superscript III (Invitrogen), and 
the cDNA was amplified by 12 cycles of PCR with Phusion high fidelity polymerase (NEB). 
Amplified cDNAs were separated on 8% polyacrylamide gels. cDNAs containing an inset size 
~100 nt were purified from the gel based on the size. The quality and quantity of the cDNA library 
were evaluated by Agilent Bioanalyzer and qPCR analysis. The strand-specific cDNA libraries 
generated by this protocol were sequenced on an Illumina Genome Analyzer IIx. RNA sequencing 
of CONS and WT samples in SC or XY media (Dataset S2) was performed using  
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3′READS, as previously described (6). Both RNA sequencing methods produced equivalent results, 
as determined by comparison of T4V vs WT samples analyzed by both methods.   
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Supplementary Figure S1. 
 
Thr4 is phosphorylated on RNAP II-transcribed genes. 
(A) ChIP analysis of phosphorylated Thr4 on CTD repeats (T4p) or RNAP II in WT, CONS, or T4V 
strains at promoter-proximal (Pr), ORF, or 3' regions of constitutively expressed PMA1 and PYK1 genes. 
Data are represented as mean +/- SD of three independent experiments. 
(B) ChIP analysis of phosphorylated Thr4 on CTD repeats (T4p) on promoter-proximal or ORF regions 
of indicated genes under their respective induced conditions. Data are represented as mean +/- SD of 
three independent experiments. 
(C) ChIP values from B were normalized to RNAP II levels, determined in the same samples at the 
same positions with an Rpb1 antibody. Data are represented as mean +/- SD of three independent 
experiments. 
(D) ChIP analysis of RNAP II occupancy at promoters of indicated genes under their respective induced 
conditions in WT or T4V cells. Data are represented as mean +/- SD of three independent experiments. 
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Supplementary Figure S2. 
 
Elevated expression of PHO gene RNAs in T4V 
RT-PCR validation of selected up- or down-regulated genes, with PMA1 control, in WT, CONS, T4V, and 
htz1∆ strains. Total RNA from samples grown in normal (SC) medium was analyzed by semi-quantitative 







Supplementary Figure S3. 
 
Gene expression change (Log2) 
T4V vs. WT 
(4,610 genes with average read # >=20) 
Comparison of RNAsequencing in CONS vs WT and T4V vs WT analyses. 
Scatterplot comparing gene expression changes from CONS vs WT (Dataset S1) and T4V vs WT (Dataset 











r = - 0.02 
P = 0.3 
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Supplementary Figure S4. 
 
List of genes strongly interacting genetically with T4V mutation in SGA screens 
Two SGA analyses were performed with WT and T4V strains. Stains expressing T4V 
and each of ~4700 deleted non-essential genes were inspected for growth defects 
compared to the same gene deletion in WT strains. Gene deletions causing the most 
severe growth defect in combination with T4V in both screens are indicated with locus 





Supplementary Figure S5. 
 
 
Htz1 is eviction from the activated GAL1 promoter is unaffected in the CONS strain. 
(A) Western blot analysis of WT, CONS, and T4V strains expressing 6x HA tagged Htz1. Levels 
of Htz1-6HA and RNAP II (Rpb1) in the same samples are shown. 
(B) ChIP analysis of Htz1-6HA occupancy at the GAL1 promoter before and after induction with 
















Supplementary Table S1. RNA-seq statistics for WT and T4V analysis.  
Sample  No. of raw reads  No. of uniquely mapped reads  
T4V replicate 1  4,216,055  3,601,290  
T4V replicate 2  5,374,604  4,580,668  
WT replicate 1  5,048,318  4,333,368  
WT replicate 2  4,502,798  3,897,106  
  
  
Supplementary Table S2. RNA-seq statistics for WT and CONS analysis.  
Sample  No. of raw reads  No. of uniquely 
mapped reads  
SC medium, CONS (“26p”), replicate 1  8,974,658  2,804,521  
SC medium, CONS (“26p”), replicate 2  10,825,427  3,353,291  
SC medium, WT, replicate 1  6,436,125  1,813,413  
SC medium, WT, replicate 2  6,778,954  1,935,444  
XY (rich) medium, CONS (“26p”), replicate 1  9,905,275  3,015,817  
XY (rich) medium, CONS (“26p”), replicate 2  4,563,665  1,416,412  
XY (rich) medium, WT, replicate 1  10,244,166  3,249,571  















Supplementary Table S3.  Yeast Strains Used in this Study All 
derivative strains were constructed for this study.  
  
Strain  Genotype  
W303a  MATa leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 The 
following strains were derived from W303a.  
ERYM745A  RPB1::RPB1-NatR  
ERYM746A  rpb1::rpb1-CTD(CONS)26-NatR  
ERYM747B  rpb1::rpb1-CTD(T4V)24-NatR  
ERYM748A  htz1∆ ::kanMX  
ERYM779A  ino80∆900::kanMX HTZ1-6HA::Kl TRP1  
ERYM749A  RPB1::RPB1-NatR HTZ1-6HA::Kl TRP1  
ERYM750A  rpb1::rpb1-CTD(CONS)26-NatR  HTZ1-6HA::Kl TRP1  
ERYM751B  rpb1::rpb1-CTD(T4V)24-NatR  HTZ1-6HA::Kl TRP1  
NYYM152A  ybr184w∆::kanMX  
NYYM153A  ybr184w∆::kanMX  rpb1::rpb1-CTD(T4V)24-NatR  
NYYM145A  swr1∆::kanMX  
NYYM146A  swr1∆::kanMX  rpb1::rpb1-CTD(T4V)24-NatR  
NYYM147A  swc5∆::kanMX  
NYYM148A  swc5∆::kanMX rpb1::rpb1-CTD(T4V)24-NatR  
The following strains were derived from the BY4172 background.  
Y7092  can1Δ::STE2pr-SpHis5 his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 lyp1Δ LYS2+   
NYYM115A rpb1::rpb1-CTD(CONS)26-NatR (derived from Y7092)  
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The RNA polymerase II (RNAP II) largest subunit C-terminal domain (CTD) 
consists of repeated YSPTSPS heptapeptides. The role of tyrosine-1 (Tyr1) remains 
incompletely understood, as, for example, mutating all Tyr1 residues to Phe (Y1F) is 
lethal in vertebrates but a related mutant has only a mild phenotype in S. pombe. Here 
we show that Y1F substitution in budding yeast resulted in a strong slow-growth 
phenotype. The Y1F strain was also hypersensitive to several different cellular stresses 
that involve MAP kinase signaling. These phenotypes were all linked to transcriptional 
changes by RNA sequencing, and we also identified genetic and biochemical links 
between Tyr1 and both transcription initiation and termination factors. Further studies 
uncovered defects related to the MAP kinase I (MPK1/SLT2) pathway, and we provide 
evidence that Slt2 phosphorylates Tyr1 in vitro and in vivo. Our study has thus identified 
Slt2 as a Tyr1 kinase, and in doing so provided links between stress response activation 





In eukaryotes, the multisubunit enyzme RNA polymerase II (RNAP II) is 
responsible for transcription of all mRNAs as well as numerous noncoding RNAs. The 
largest subunit of RNAP II, Rpb1, contains a C-terminal domain (CTD) consisting of 26 
(in yeast) to 52 (in vertebrates) heptad repeats, the consensus sequence being Tyr1-
Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 (Allison et al. 1985; Corden et al. 1985; Corden 1990; 
Liu et al. 2010; reviewed by Hsin and Manley 2012). The non-proline residues are all 
subject to phosphorylation and de-phosphorylation during the transcription cycle, and 
the different residues, and their modification, appear to serve distinct roles related to the 
stage of transcription (reviewed in Phatnani and Greenleaf 2006; Eick and Geyer 2013; 
Napolitano et al. 2014; Conaway and Conaway 2015). The CTD thus functions in 
essentially all aspects of the synthesis and processing of RNAP II transcripts, which 
includes not only initiation, elongation and termination of transcription, but also all the 
processing reactions, such as 5’ capping, splicing and 3’ end formation.  
Of the phosphorylatable CTD residues, serines 2 and 5 have received the most 
attention. Ser5 phosphorylation is concentrated near the 5’ end of genes, primarily as a 
result of the TFIIH-associated kinase Kin28 (Feaver et al. 1994), where it functions in 
recruitment of capping enzyme and a number of factors important for transcriptional 
elongation (Cho et al. 1997; Ng et al. 2003; Govind et al. 2007). Additionally, the 
multisubunit Mediator takes advantage of CTD flexibility and aids in Kin28 
phosphorylating all CTD heptads by guiding it through the Mediator-PIC (pre-initiation 
complex) head module (Robinson et al. 2016). Ser5P is also directly recognized by 
Nrd1 of the NNS complex, which also consists of Nab3 and Sen1, to terminate 
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transcription of short RNAP II products, including cryptic unstable transcripts (CUTs), 
stable uncharacterized transcripts (SUTs) and small nucleolar RNAs (Arigo et al. 2006, 
Vasiljeva et al. 2008). The primary driver of Ser2 phosphorylation in yeast, Ctk1, is 
responsible for the bulk of Ser2P, which accumulates towards the 3’ end of genes 
(Mayer et al. 2010). Ser2P levels peak near 3' cleavage-polyadenylation sites, where 
termination factors such as Pcf11 and Rtt103 interact directly with the CTD, facilitating 
3' processing and termination (Kim et al. 2004; Luo et al. 2006).  
Determining the function of Ser2 and Ser5, as well as other residues in the 
heptad repeat, has benefited from the strategy of directly modifying the CTD. Besides 
direct substitution mutations (e.g., Ser-to-Ala), more recent efforts (Schuller et al. 2016; 
Suh et al. 2016) have altered the CTD to allow detection of phosphorylation patterns 
using mass spectrometry. These studies confirmed that all non-proline residues are 
phosphorylated, although replacing many individual residues (mostly Ser7) with lysine 
and arginine (enabling trypsin cleavage) produced a slow growth phenotype under cold 
stress (Suh et al. 2016). Extending the importance of Ser2 and Ser5, these studies 
found that Tyr1 and Thr4 phosphorylation was much less abundant compared to Ser2/5, 
although whether or not this was due to an effect of the other CTD modifications or to 
the relative importance of Tyr1/Thr4 under the growth conditions used is not clear. 
The other phosphorylatable CTD residues (Ser7, Thr4 and Tyr1) appear to 
perform more specialized roles (reviewed in Yurko and Manley 2017). After Ser2 and 
Ser5, Ser7 phosphorylation has been well characterized, and is present on RNAP II on 
active genes (Chapman et al. 2007). Ser7 is also important for proper small nuclear 
RNA gene expression, such as U1/U2 snRNA 3' end formation, in mammals (Egloff et 
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al. 2007), and enables better recruitment of the functional human homolog of Ctk1, P-
TEFb, to the CTD (Mayer et al. 2010; Czudnochowski et al. 2012). Thr4 has been found 
to have differing roles depending on the organism. In chicken cells expressing a T4V 
derivative, histone mRNA 3’ processing was found to be defective (Hsin et al. 2011), 
and both the chicken T4V and human T4A (Hintermair et al. 2012) were lethal. In 
budding yeast, Thr4 is required for the induction of certain classes of genes, and is 
necessary for proper variant histone H2A.Z eviction and induction of PHO and GAL 
metabolic genes (Rosonina et al. 2014). Recent work also revealed a role in budding 
yeast for Thr4 in splicing and Rtt103 recruitment (Harlen et al. 2016). 
The function of Tyr1 has only more recently been investigated. Chicken DT40 
cells expressing a Y1F derivative were inviable, and also revealed that a function of 
Tyr1, and its phosphorylation, was stabilization of the CTD (Hsin et al. 2014). Tyr1 was 
also required for efficient turnover of certain unstable transcripts, such as upstream 
antisense RNAs (uaRNAs), and Tyr1 phosphorylation was indeed elevated on regions 
encoding uaRNAs. Very similar results were observed in human cells (Descostes et al. 
2014). A Y1F derivative was also found to be lethal in budding yeast (West and Corden 
1995), and Tyr1P patterns along yeast genes are similar to Ser2P (Mayer et al. 2012). 
Tyr1 phosphorylation is also important for histone chaperone Spt6 binding (Burugula et 
al. 2014), and the presence of Tyr1P impairs Nrd1 and Rtt103 interaction with CTD 
peptides, suggesting a role in modulating termination (Lunde et al. 2010; Mayer et al. 
2012). Surprisingly, in fission yeast Tyr1 can be mutated with no loss of viability, 
although cold- and iron-sensitivity phenotypes were noted (Schwer and Shuman 2011; 
Schwer et al. 2012, 2014). While evidence exists that Tyr1 can be phosphorylated by 
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the c-Abl kinase in mammals (Baskaran et al. 1993), the responsible kinase(s) in yeast, 
where tyrosine phosphorylation is rare, is unknown.  
Here, we investigate the role of Tyr1 and Tyr1P in S. cerevisiae. We first 
generate a strain that expresses a full-length Y1F form of the CTD and show that the 
strain is viable but very slow growing under normal conditions. We identify genetic links 
between the Y1F mutant and Mediator, and found that the Y1F phenotype can be 
partially suppressed by removing Srb10/11 subunits. We also found that several stress-
response genes dealing with cell wall, oxidative, and related stress responses, as well 
as iron response (Schwer et al. 2014), are dysregulated in Y1F cells, and that the cells 
are hypersensitive to stressors that specifically target these pathways. Bringing these 
observations together, we demonstrate that the specific MAP kinase involved in these 
processes, Slt2, phosphorylates Tyr1 in vitro, and that in vivo Slt2 is necessary for full 
Tyr1 phosphorylation and modulates Tyr1P levels during stress responses. These 
effects are accompanied by defects in transcription termination factor recruitment, as 
Y1F disrupts Rtt103 binding to the CTD and impairs Nrd1 recruitment to chromatin. Our 
study thus links Tyr1 with Slt2-mediated stress responses, at least in part via anti-
termination, and reveals Slt2 as a Tyr1 CTD kinase. 
 
Results 
Mutation of all CTD Tyr1 residues results in severe growth defects 
In this study, we wished to gain more insight into the function of CTD Tyr1 in 
budding yeast. In our previous work, we found that replacing the CTD of chicken Rpb1 
with a Tyr1-to-Phe (Y1F) derivative resulted in lethality (Hsin et al. 2014), consistent 
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with an earlier study in budding yeast (West and Corden 1995), but in contrast to similar 
experiments with S. pombe (Schwer et al. 2014). All of these studies, however, 
employed truncated CTDs, and we therefore constructed a yeast Y1F strain containing 
26 FSPTSPS repeats (Figure 1A, see Experimental Procedures). As a control, an all-
consensus YSPTSPS CTD was inserted into the same background, as we had done in 
our previous analysis of Thr4 (Rosonina et al. 2014).  
We next determined several properties of the Y1F strain, which we will refer to 
simply as Y1F. Comparing the growth of the parental strain (WT), consensus (CON), 
and two separate Y1F (Y1F 2A and 2B) strains revealed that Y1F displayed a severe 
slow-growth defect on both rich and synthetic complete media (Figure 1A). This 
phenotype was somewhat alleviated by growing at 37oC, but, consistent with related 
results in fission yeast (Schwer et al. 2014), Y1F was cold sensitive and unable to grow 
at lower temperatures (Figure 1A). Tetrad analysis showed that the slow growth 
phenotype was specific to the Y1F mutation, suggesting the absence of suppressors 
that would prevent lethality (Figure S1A), and the slow growth defect was also observed 
in liquid media (Figure S1B). Cell-cycle analysis showed that Y1F cells are defective in 
exiting G1/G0 and entering G2 (Figure 1B). 
We next examined accumulation of Rpb1 and its phosphorylation status by 
Western blot (Figure 1C). As expected, the WT strain showed evidence of Tyr1P as well 
Ser2P and Ser5P. However, Y1F Rpb1, while as expected not detected by an anti-
Tyr1P antibody (3D12), was also not recognized by antibodies specific for 
unphosphorylated consensus repeats (8WG16) or Ser2P (3E10). This likely indicates 
an inability of these antibodies to recognize the Y1F epitope (see below). Indeed, a 
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different Ser2P antibody (H5) produced a much stronger signal with the Y1F CTD, 
although whether this represents a bona fide increase in Ser2P, an increase in Ser2P 
with Ser5P (see Phatnani and Greenleaf 2006; Chapman et al. 2007; Devaiah et al. 
2012), or differential recognition due to an altered epitope, is not known. Ser5P levels 
appeared unaffected using the antibody 3E8. Finally, analysis with an antibody (y-80) 
that recognizes an epitope in the first 80 amino acids of Rpb1 showed that Y1F Rpb1 
accumulated to levels comparable to WT and CON Rpb1, and was full length. This 
contrasts with the situation in vertebrate cells, where Y1F mutations resulted in CTD 
destabilization (Descostes et al. 2014; Hsin et al. 2014). Additionally, levels of the 
hyperphosphorylated Rpb1 IIo isoform were also similar, suggesting that the apparent 
differences in Ser2P most likely reflected differences in epitope recognition by the 
phospho-specific Abs. Supporting the conclusion that Ser2 phosphorylation was 
unaffected, a co-immunoprecipitation (co-IP) assay with WT or Y1F Rpb1 and Ctk1 (the 
primary Ser2 kinase) revealed no changes in Ctk1 association with Rpb1, providing 
evidence that Ser2 phosphorylation by Ctk1 was not affected by the Y1F mutation 
(Figure 1D). 
Tyr1 interacts genetically with Mediator subunits SRB9/10/11  
To investigate what pathways are affected by the Y1F mutation, we carried out a 
synthetic genetic array assay (SGA) (Tong et al. 2001, Rosonina et al. 2014). Due to 
the slow growth phenotype of the Y1F mutant, we performed the SGA as a suppressor 
assay, using a 5FOA-URA3 system with a plasmid-borne WT copy of Rpb1, comparing 
Y1F and CON strains (Poschke et al. 2012). Genes related to transcription found in 
each of two independent suppressor SGA analyses are listed in Figure 2A (the 
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complete list is in Dataset S1), and those that best suppressed the Y1F slow growth 
phenotype are shown in Figure 2B. Sample tetrad dissections are shown in Figure S2A, 
and suppression of the Y1F growth defect could also be observed in liquid cultures, 
(Figure S2B). Interestingly, subunits of the Srb10/11 Mediator kinase module, including 
its scaffolding protein (Srb9), suppressed the Y1F phenotype when deleted, and were 
responsible for three of the four strongest interactions detected. The Srb10/11 
kinase/cyclin pair is known to inhibit transcription of numerous genes (many as part of 
the general stress response) and can phosphorylate transcription factors such as Gcn4 
to dampen activation, in tandem with other post-translational modifications such as 
ubiquitination and SUMOylation (Chi et al. 2001; Nelson et al. 2003; Bose et al. 2005; 
Rosonina et al. 2012; Allen and Taatjes 2015). The other strongest hit, Ubp8, is a 
component of the SAGA complex, a histone acetyltransferase that functions as a 
transcriptional activator. Ubp8 is a ubiquitin-specific protease required for 
deubiquitination of histone H2B (Lee et al. 2005; Koutelou et al. 2010; Wilson et al 
2011). 
We next investigated the significance of the Srb10/11 SGA suppressor result. For 
this, ChIP assays were conducted using 3HA-tagged strains in both WT and Y1F 
backgrounds. Four genes regulated by Srb10/11 (FKS2, encoding a cell wall enzyme 
[de Virgilio 2012], cell-cycle coordinator CLN2 and meiosis regulator IME1 [Ohkuni and 
Yamashita 2000], and PMA1 [Cai et al. 2006]) and two genes not subject to Srb10/11 
regulation (ZIM17 and PYK1) were analyzed. We detected a roughly two-fold increase 
in promoter occupancy of Srb10/11 on all four target genes in the Y1F strain, while 
occupancy on the genes without a link to Srb10/11 was not affected (Figure 2C). This 
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suggests genes regulated by Srb10/11, which include stress response and cell-cycle 
genes (Dynlacht 1997; Krasley et al. 2006), are especially sensitive to Y1F, possibly 
explaining the Y1F cell-cycle defect. We note that although SRB mutations have long 
been known to suppress truncated CTD derivatives (Hengartner et al. 1995; Yuryev and 
Corden 1996), suppression of a full-length Y1F CTD likely reflects a distinct mechanism 
reflecting enhanced Srb10/11 promoter occupancy. These findings are discussed in 
more detail below. 
Tyr1 is required for proper expression of stress-mediated genes  
We next wished to extend our analysis by examining directly how Y1F alters 
global gene expression. To this end, we performed mRNA sequencing (RNA-seq) using 
3’READS (Hoque et al. 2013) with WT and Y1F strains grown in rich medium. This 
method allowed us to determine possible effects of the Y1F on alternative 
polyadenylation as well as mRNA levels. In addition to a general shift favoring distal 
poly(A) site usage (Figure S3), changes in expression of multiple genes were observed. 
Expression of 5,925 genes are tabulated in Dataset S2. Transcript levels of 306 genes 
were significantly increased, while 329 were reduced (adjusted P-values less than 
0.05). GO analysis was then performed, with the top associated terms listed in Figure 
3A. Consistent with the SGA and/or previous work (Schwer et al. 2014), terms enriched 
from this analysis include cell wall stress, iron homeostasis, and processes related to 
oxidoreductive stress. Correlations between samples, which was as high as 0.94 for 
significant genes, are shown in Figure S4. Additionally, a significant upregulation of both 
CUTs (P-value of 7.49 x 10-12) and SUTs (P-value of 2.23 x 10-5) was detected (Figure 
S5). RT-PCR analysis of a sample (12) of the genes with altered expression validated 
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the RNA-seq results (Figure 3B). Among these were FKS2 (associated with multiple 
stress responses), SIT1 (iron stress response), and CAP2 (DNA damage response). 
We also compared our data with an existing Tyr1P ChIP dataset (Mayer et al. 
2012). Out of our 630 genes displaying altered expression in Y1F cells, 498 were also 
found in the Mayer dataset (222 up-regulated, 276 down-regulated). Strikingly, the up-
regulated genes had a Tyr1P ChIP signal weaker than average (P-value of 4.45 x 10-8) 
whereas the down-regulated genes had a Tyr1P signal stronger than average (P-value 
of 6.60 x 10-10) (summarized in Figure S6). These results provide a strong correlation 
between genes with altered expression in Y1F cells and levels of Tyr1 phosphorylated 
RNAP II. 
The GO analysis described above suggested that expression of genes involved 
in several specific stress responses was altered in Y1F cells. Notably, however, the 
expression changes detected were not due to a generalized stress response (Gasch et 
al. 2000; O’Duibhir et al. 2014), as there was poor overlap between our Y1F data and 
the Extended Stress Response (ESR) gene set identified by Gasch et al. (11 out of 138 
genes from the ESR overlapped). Interestingly, though, we noted that cell wall and iron 
stress responses both require MAP kinase signaling, specifically the MAPK Slt2, for 
proper function, and the DNA damage/oxidative stress response does as well (Levin 
2005, 2011; Pujol-Carrion et al. 2013; Soriano-Carot et al. 2012). We therefore next 
examined possible links between Y1F and stress responses involving MAP kinases. To 
this end, we compared growth of Y1F and WT in medium containing compounds that 
perturb MAP kinase-associated pathways (Figure 3C). These include calcofluor white 
(CFW), phleomycin, hydroxyurea, FK506, and rapamycin.  Strikingly, with three of the 
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compounds (CFW, phleomycin, and hydroxyurea), Y1F was completely inviable while 
WT growth was unaffected, and both rapamycin and FK506 slowed growth of Y1F 
significantly more than WT. Additional stress pathways not known to involve Slt2 (e.g., 
galactose metabolism, high salt and low phosphate conditions) were also tested and 
found not to significantly alter growth of Y1F compared to WT (Figure S7). These 
observations, together with the RNA analysis above, indicate that although Tyr1 is not 
required for normal expression of most genes under normal growth conditions, a subset 
of MAP kinase-induced genes, and those important for MAP kinase function (such as 
MKK1), require Tyr1. This in turn implicates Tyr1, and perhaps its phosphorylation, in 
the response to MAPK-related stresses. 
Slt2 phosphorylates Tyr1 in vitro and in vivo 
The above data suggesting that MAPK signaling pathways are defective in Y1F 
cells raises the possibility that a kinase in this pathway may naturally function to 
phosphorylate Tyr1. Two candidates are Slt2 and Hog1, both of which are Ser/Thr 
kinases that have also been shown capable of Tyr phosphorylation (Levin-Salomon et 
al. 2009; Maayan et al. 2012). Slt2 is a component of the PKC1 signaling pathway 
(reviewed by Pearson et al. 2011), which regulates the cellular response to several 
stresses, such as heat shock, cell wall stress, and DNA damage, through MAP kinase 
cascades (Soriano-Carot et al. 2012). Slt2 acts in transcription through phosphorylation 
of transcription factors (TFs), such as the Swi4/Swi6 complex, also known as SBF 
(Koch et al. 1996; Kim and Levin 2010; Kahana-Edwin et al. 2013). Activated Slt2 is 
recruited to promoters to increase transcription by phosphorylating TFs as well as by 
mediating destruction of Srb11, thereby further increasing transcription (Madden et al. 
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1997; Baetz et al. 2001; Jung et al. 2002; Levin 2011). Furthermore, Slt2 promotes 
transcription of stress related genes not only by phosphorylation of SBF and other TFs, 
but also by blocking association of the NNS complex, preventing early transcription 
termination (Kim and Levin 2011; see also Kim et al. 2008). Hog1 functions in the 
cellular response to osmotic stress, and is homologous to p38 and JNK kinases in 
mammals (reviewed in Brewster and Gustin 2014). Hog1 controls expression of more 
than 300 genes by association with the RNAP II complex at promoters (Rep et al. 
2000). 
In light of the above, we tested the possibility that Slt2 and/or Hog1 have Tyr1 
kinase activity. We first used an in vitro kinase assay (adapted from Campbell 2014) to 
determine if either kinase can phosphorylate a GST-CTD derivative. For this, we 
generated 3HA-tagged versions of Slt2 and Hog1 to allow us to immunoprecipitate (IP) 
these kinases from cell extracts. We IPed HA-tagged Slt2 and Hog1 from WT cells 
(after activating the kinases through exposure to the appropriate stress conditions, i.e. 
CFW or NaCl, respectively), incubated them with a purified GST-CTD fusion protein, 
and analyzed phosphorylation by Western blot with CTD phospho-specific antibodies 
(Figure 4A). Importantly, we found that Slt2, but not Hog1, can indeed phosphorylate 
Tyr1. Consistent with previous data (Akhtar et al. 2009; Chasman et al. 2014), Slt2 and 
Hog1 also phosphorylated Ser2 and Ser5. As controls, strains carrying kinase-dead 
(KD) HA-tagged derivatives of these two kinases (see Kim et al. 2008; Irqeba et al. 
2014) were prepared and used in the in vitro kinase assay. Neither KD derivative 
showed any kinase activity (Figure 4A). As additional controls for specificity, we 
constructed and analyzed strains expressing 3HA-tagged Kin28 and Ctk1, which 
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phosphorylated Ser2 and/or Ser5 but not Tyr1 (Figure S8). Our data thus provide strong 
evidence that Slt2 possesses CTD Tyr1 kinase activity. 
We next investigated whether Slt2 can affect Tyr1 phosphorylation status in vivo. 
For this, we first subjected WT cells to MAPK pathway-related stresses, specifically cell 
wall stress resulting from exposure to CFW and DNA damage stress from phleomycin 
exposure. Strikingly, Western blot analysis of cell lysates revealed a significant increase 
in Tyr1P following CFW exposure (3.0-fold after one hour, normalized to Rpb3 levels), 
but not of Ser2P or Ser5P (Figure 4B, quantified in Figure 4C). While phleomycin 
treatment resulted in a decrease in Tyr1P after 15 minutes, a net 1.5-fold increase was 
observed after one hour (Figure 4B). Slt2 levels following CFW and phleomycin 
exposure were increased relative to the DMSO alone control (following a decrease after 
15 minutes in the case of phleomycin), while Hog1 levels were unchanged by either 
treatment (Figure 4B). To determine whether the increased Tyr1P was in fact due to 
Slt2, we generated strains carrying deletions in SLT2 (S∆), HOG1 (H∆), or both genes 
(SH∆). We also analyzed the kinase-dead strains described above (SM and HM). WT 
cells were grown under normal conditions (SLT2 mutant strains are inviable in the 
presence of CFW [van Voorst et al. 2006]), and lysates analyzed by Western blot 
(Figure 4D). Importantly, Tyr1P was significantly reduced in the S∆, S-KD and SH1∆ 
strains (1.8- , 1.9- , and 3.0- fold, respectively), but not in the H∆ and H-KD strains. 
These findings strongly support our in vitro data that Slt2 is a Tyr1 kinase, although as 
Tyr1P was not completely abrogated in the SLT2 mutant strains, another unknown 
kinase may also target Tyr1.   
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We extended this analysis to another MAPK-related stress, heat shock. 
Consistent with earlier studies (Kamada et al. 1995; Kim et al. 2010), and similar to 
what we observed following CFW exposure, heat shock resulted in an increase in 
overall Slt2 levels (Figure 4E). Importantly, heat shock induced a 3.4-fold increase in 
Tyr1P, while Rpb1 levels and Ser2P/Ser5P were unchanged. Due to lethality of heat 
exposure for SLT2 mutants (Torres et al. 1991), we were unable to measure Tyr1P 
levels under heat stress in the deletion and kinase-dead strains described above. 
We next examined if Slt2 associates with RNAP II, and if so how this might be 
affected by Y1F, and whether this correlates with Tyr1P levels. To this end, we 
performed coIP assays with extracts from WT and Y1F cells expressing 3HA-tagged 
Slt2 (Figure 5A). Using the y-80 antibody for IP, we found that Slt2 was coIPed with 
RNAP II from WT cell extracts, but not from Y1F extracts. (DNAse treatment did not 
alter the results; data not shown). To extend these results, we prepared extracts from 
WT cells expressing 3HA-tagged Slt2, either growing normally or treated with CFW to 
activate the kinase, and from normally growing cells expressing 3HA-tagged KD Slt2. 
Extracts were IPed with anti-HA antibodies and Western blots probed with anti-Tyr1P, -
Rpb1, -Ser2P and -Rpb3 antibodies. Strikingly, Slt2-associated Tyr1P levels were 2.3-
fold higher in the extracts from activated relative to normal cells, while 0.6-fold lower in 
the kinase-dead strain (Figure 5B); no changes in Rpb1, Ser2P, or Ser5P levels were 
detected. Taken together, our findings establish Slt2 as a CTD Tyr1 kinase, and in 
doing so link Slt2-mediated Tyr1 phosphorylation with the cellular stress response. 
Y1F alters Nrd1 and Rtt103 interactions with RNAP II 
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We next wished to investigate how Tyr1, and its phosphorylation by Slt2, might 
affect target gene expression. Since Tyr1 phosphorylation and Slt2 activity are both 
known to influence association of certain termination factors with the transcription 
machinery (Satoh et al. 2009; Kim and Levin 2011; Heidemann and Eick 2012; Mayer et 
al. 2012; Porrua and Libri 2015), and the Y1F strain shows a general shift to distal 
poly(A) site usage and upregulation of both CUTs and SUTs (Figures S3 and S5), we 
examined if recruitment of such factors is altered by Y1F. To do this, we attempted to 
generate 3HA-tagged versions of Nrd1, Rtt103 and Pcf11, three proteins previously 
shown to interact with the CTD peptides in a Tyr1P-sensitive manner (Mayer et al. 
2012), in WT and Y1F backgrounds. While we were unable to tag Pcf11 in the Y1F 
strain, as Y1F and the Pcf11 tag were synthetically lethal, we did generate Nrd1- and 
Rtt103- tagged strains. These were then used in coIP experiments, using the y-80 
antibody. Consistent with earlier predictions (Mayer et al. 2012), Y1F Rpb1 showed a 
7.3-fold increase in Nrd1 binding (Figures 6A). In contrast, Rtt103 levels in the co-IP 
were significantly reduced in the Y1F strain (Figure 6B). Although not entirely as 
expected (Mayer et al. 2012), a possibility consistent with previous studies (Lunde et al 
2010; Mayer et al. 2012) is that Rtt103 requires the hydroxyl group of Tyr1, which 
phosphorylation as well as Phe substitution disrupts, to bind the CTD efficiently. Ser2 
(Lunde et al. 2010) and Thr4 (Jasnovidova et al. 2017) are also required for this 
association. 
We next examined Nrd1 occupancy in WT and Y1F strains on genes known to 
be Nrd1/NNS targets. Using ChIP, we found unexpectedly that Nrd1 levels, normalized 
to Rpb1 occupancy, decreased in the Y1F strain near promoters for FKS2, IMD2 and 
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HRP1 (all previously shown to be Nrd1/NNS targets; Kim and Levin 2011, Steinmetz et 
al. 2006), as well as for ZIM17 (one of the most significantly downregulated genes in 
Y1F; see Figure 3A). In contrast, Nrd1 occupancy on PMA1, not known to be an NNS 
target, was not affected (Figure 6C). This decreased Nrd1 occupancy on target 
promoters is consistent with the general upregulation of CUTs and SUTs we observed 
in Y1F cells (see above).  
To gain more insight into how Y1F effects Nrd1 occupancy on target promoters, 
we examined Nrd1 and Slt2 occupancy on a target gene following heat shock. To this 
end, we generated paired Nrd1 and Rpb1 ChIP samples from control and heat-shocked 
WT and Y1F cells, and analyzed both Nrd1 and Slt2 occupancy on FKS2, which has 
served as an important model gene for both NNS function and MAPK signaling (Kim et 
al. 2008; Kim and Levin 2011). We found that Nrd1 occupancy relative to Rpb1 at the 
promoter region was reduced following heat shock in WT cells, as expected (Kim and 
Levin 2011). However, upon heat shock Nrd1 occupancy relative to Rpb1 in Y1F cells 
increased significantly (2.5-fold; Figure 6D), indicating that Tyr1, and likely its 
phosphorylation, is required for loss of NNS following heat shock. Supporting a role for 
Slt2 in this process, while heat shock resulted in Slt2 recruitment to promoters in WT 
cells, as observed previously (Kim and Levin 2011), this was not observed in Y1F cells 
(Figure 6E), consistent with the co-IP results shown above. Together, and as discussed 
in more detail below, our results implicate Tyr1 and its phosphorylation by Slt2 in 





Our studies have provided new insights into the function of RNAP II CTD Tyr1 
residues in budding yeast. While previous analyses of Tyr1 function in vertebrate cells 
(Descostes et al. 2014; Hsin et al. 2014) point to significant differences between yeast 
and higher eukaryotes, one notable similarity is that this highly conserved residue plays 
relatively specific roles in gene expression. We have shown here that Tyr1 is required 
for expression of a subset of stress-inducible genes, notably MAP kinase-associated 
genes. Importantly, we found that Tyr1 is phosphorylated by Slt2 in vitro, and that the 
levels of Tyr1P in cells can be modulated by exposure to specific stresses known to 
require Slt2 function, or by inactivating the kinase. Given previously defined roles of 
both Tyr1 and Slt2 in anti-termination, we provided evidence for Slt2 and Nrd1 co-
regulation of stress-related target transcripts, showing that Tyr1 provides a nexus at 
which stress response and anti-termination meet to influence transcription. Below, we 
discuss how Slt2 activity and Tyr1 serve as the connection for these processes in 
budding yeast, as well as the varied roles Tyr1 and its phosphorylation play throughout 
evolution. 
Our data implicate Tyr1 in the proper function of the cell wall integrity pathway, 
which provided the first suggestion that Slt2 may function as a Tyr1 kinase. Upon 
sensing cell wall stress, such as through activation of the cell wall sensor Mid2, the 
Rho1 effector pathway is activated, which in turn activates the MAP kinase Pkc1, 
triggering a kinase cascade resulting in activation of Slt2 (Posas et al. 1998; Levin 
2005). Slt2 has a diverse number of nuclear targets, many of them transcription factors 
such as Swi4 of the SBF complex (Baetz et al. 2001). Activated Slt2 is characterized by 
a phosphorylated TxY activation loop, which changes the conformation of the protein to 
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allow for sustained phosphorylation of targets (Chen and Thorner 2007, Truman et al. 
2009). While previous investigations of Slt2 focused on serine phosphorylation, removal 
of the C-terminus of Slt2 enables autophosphorylation of the TxY activation loop itself, a 
method of regulation that has in fact been observed in higher eukaryotes (Levin-
Salomon et al. 2009; Goshen-Lago et al. 2016; Smorodinsky-Atias et al. 2016).  
The involvement of Srb10/Srb11, two of the suppressors identified in the SGA, in 
stress responses has been known for some time. The kinase/cyclin pair is a target of 
Slt2, with Slt2 phosphorylation leading to degradation of Srb11 (Jin et al. 2014; Strich 
and Cooper 2014). Previous genetic studies have linked Srb10/11 function to Slt2 
response, as this module of Mediator is linked to heat, oxidative and anaerobic stress 
through regulation of the TF Skn7 (Arias et al. 2011). The association between oxidative 
and cell wall stresses and Srb11 has been known longer, since it was found that Ask10 
(“Activator of Skn7”) directly mediates the destruction of Srb11 in response to oxidative 
stress using the Pkc1 pathway (Cohen et al. 2003). Additionally, increased expression 
of certain stress response genes, particularly iron response, upon phosphorylation of 
Mediator subunit Med2 by Srb10, has been observed (van de Peppel et al. 2005), which 
is consistent with our ChIP and RNA analyses. Our data that Tyr1 is required for loss of 
Srb10/11 from target genes extends the role of Slt2 in the cell wall integrity (CWI) 
pathway, which previously was not known to target RNAP II directly. Previous work 
established Slt2's role in facilitating Srb11 translocation from nucleus to cytoplasm (Jin 
et al. 2014) subsequent to its degradation by the proteasome (Cooper et al. 1997, 
Krasley et al. 2006, Strich and Cooper 2014). This function is impaired in Y1F cells, as 
Srb10/11 occupancy on several target promoters increased in these cells, and Slt2 was 
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not recruited to at least one of these genes (FKS2), likely reflecting its defective 
interaction with Y1F RNAP II. 
The involvement of Slt2 in the expression of stress response-related genes has 
been well documented. Our data extend these findings by showing that Tyr1 
phosphorylation by Slt2 is critical in several stress responses. Besides the canonical cell 
wall integrity pathway, as exemplified by sensitivity to calcofluor white (reviewed in 
Levin 2005, 2011), Slt2 is also involved in the response to DNA damaging agents such 
as hydroxyurea and phleomycin (Soriano-Carot et al. 2012), and functions along with 
calcineurin upon exposure to FK506 (Mizunuma et al. 1998). Additionally, in concert 
with TORC1 signaling, Slt2 helps stabilize the cell’s response to rapamycin (Moreno-
Torres et al. 2015), and also serves as a target of TORC1 phosphorylation upon 
caffeine exposure (Kuranda et al. 2006). Importantly, many of the genes with altered 
expression in Y1F were already known to be regulated by Slt2, as part of the above 
stress responses. In a related Y1F S. pombe strain, a similar response to phleomycin 
was observed, which was the result of iron uptake pathway upregulation generating 
excess intracellular iron, potentiating phleomycin activity (Schwer et al. 2014). Our study 
extends this finding significantly, not only by expanding the role of Tyr1 in the stress 
response to most Slt2-dependent responses, but also by involving Tyr1-dependent 
interactions directly in Slt2 function. We thus expect additional Slt2-dependent stress 
responses to involve Tyr1, either through direct Tyr1 phosphorylation or indirectly 
through regulation of other Slt2 targets. 
Previous studies of Tyr1 revealed differences in the distribution of Tyr1P between 
species, as well as the importance of the residue to termination factor recruitment. 
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Genome-wide ChIP analyses in S. cerevisiae showed that Tyr1P reaches a peak at the 
3’ end of genes, although it begins to accumulate towards the 5’ end, much like Ser2P 
(Mayer et al. 2012). This is in contrast to human cells, which show a peak at the 5’ end 
of genes as well as in the antisense direction, and at transcriptional enhancers 
(Descostes et al. 2014). Further differentiating yeast and human cells, there is no clear 
human Nrd1 homolog, and the processing of snRNAs is done differently through the 
Integrator complex (Baillat et al. 2005, O’Reilly et al. 2014). It would make sense, then, 
that the functions associated with Tyr1 differ between yeast and human cells; the 
proposed function of Tyr1P in budding yeast (preventing termination factors Nrd1, Pcf11 
and Rtt103 from prematurely binding to the CTD) seems to be yeast specific (Mayer et 
al. 2012). The involvement of Tyr1 in the stress responses we have shown here, 
mediated in part by the Nrd1/NNS complex, may also be yeast specific, but further 
studies will be needed to investigate this. 
Our data provide new insight into the CTD interaction with the NNS complex. The 
substantial increase in Nrd1 binding to the Y1F CTD we observed is consistent with 
previous studies showing that Tyr1P-containing CTD peptides bound Nrd1 less strongly 
than unmodified peptides (Mayer et al. 2012). The finding that upon cell stress, Slt2 is 
induced and recruited to coding regions as well as promoters of specific genes links Slt2 
with NNS function, as NNS association with elongating RNAP II drops with Slt2 
induction (Kim and Levin 2011). While the presence of Slt2 on target genes was 
suggested to be sufficient for anti-termination (Kim and Levin 2011), our data provide 
evidence that Slt2 phosphorylation of Tyr1 is critical for this process by facilitating 
dissociation of NNS. Importantly, our findings that Tyr1P levels increase in response to 
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stress link Tyr1 phosphorylation by Slt2 with activation of stress-related genes. Based 
on these findings, we propose a model (Figure 7) that incorporates not only Slt2, Tyr1P 
and NNS, but also Srb10/11 and SBF, known targets of Slt2 (Jin et al. 2014, Kim et al. 
2008) now linked to CTD Tyr1, into activation of stress response genes. While some of 
our observations were obtained from single-gene experiments, and thus may not apply 
in all circumstances, we believe the robust responses from our model system are 
indicative of more general mechanisms. 
The significance of tyrosine phosphorylation in budding yeast is not entirely clear. 
S. cerevisiae encodes no typical tyrosine kinases, and the relative levels of TyrP are 
extremely low (<0.1% total phosphorylation; Modesti et al. 2001; Chi et al. 2007). 
Previous reports of Tyr phosphorylation have typically involved specialized functions, 
such as phosphorylation of heat shock protein Hsp90 by Swe1 (Mollapour et al. 2010). 
Tyr phosphorylation also occurs in the CWI pathway, as Mkk1 phosphorylates the Thr 
and Tyr residues of the Slt2 activation loop (Martín et al. 2000). Other dual-specificity 
kinases have been identified, including Hrr25 (Hoekstra et al. 1994), Yak1 (Kassis et al. 
2000) and Kns1 (Lee et al. 1996). Our study adds Slt2 to this list, and establishes an 
important role for it in transcriptional control. Since inactivation of Slt2 did not abolish 
Tyr1 phosphorylation in vivo, it is likely that Tyr1 can be targeted by additional kinase(s), 
and it will be of interest to determine whether such kinases come from this group of 
dual-specificity kinases.  
It remains to be seen how our findings on Tyr1 function extend to other 
organisms. As mentioned above, the corresponding Y1F mutation in S. pombe, despite 
the truncated CTD, did not cause nearly as strong a growth defect as the S. cerevisiae 
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derivative we analyzed (Schwer and Shuman 2011; Schwer et al. 2014). Notably, the S. 
pombe Y1F derivative retained a Tyr1-containing 4-repeat “rump,” offering at least a 
partial explanation for the relatively mild growth defects observed. The S. pombe and S. 
cerevisiae derivatives did however show similarities, including sensitivity to cold and 
phleomycin, and it is possible that future studies will reveal defects in additional stress 
pathways. It will also be of interest to determine whether the S. pombe Slt2 homologue, 
Pmk1, which functions in pathways similar to Slt2 (Toda et al. 1996, Madrid et al. 2006), 
is a Tyr1 kinase. Regulation of transcription by MAP kinase pathways also extends to 
higher eukaryotes, as homologs of Slt2, such as Erk1/2, were found to be recruited to 
chromatin in a manner similar to Slt2, on similar stress-induced genes (Pokholok et al. 
2006; Yang et al. 2013; Mikula et al. 2016). Indeed, Erk1/2 are well known to have CTD 
Ser5 kinase activity (Trigon et al. 1998; Bonnet et al. 1999), although there is no 
evidence that they can target Tyr1. While there are significant differences between 
yeast and human cells in their response to stress (Verghese et al. 2012), it will be of 
interest to determine whether additional mechanisms evolved in human cells to amplify 
or refine signaling through Tyr1. In any event, our results show that Tyr1 and its 
phosphorylation by Slt2 play an important role in regulating transcription in response to 
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Experimental Procedures 
Yeast strains and growth media 
Yeast strains used are listed in Table S1. Y1F and CONS strains were constructed by 
PCR amplification of corresponding CTD constructs generated for use in previous 
studies (Hsin et al. 2011, Hsin et al. 2014), followed by transformation into haploid (for 
CONS) or diploid (for Y1F) S288C or BY4741/2 strains. The diploid strains carrying the 
Y1F CTD along with NAT-MX cassette (see Tong and Boone 2006, Rosonina et al. 
2014) 3’ of the RPO21 gene were then confirmed by PCR, sporulation and tetrad 
dissection. The CONS strain was also marked with the NAT-MX cassette 3’ of the 
RPO21 gene. Media containing FK506 (75 to 150 ug/uL), caffeine (5 mM), rapamycin 
(10 nM), phleomycin (1 ug/uL), or calcofluor white (3.5 ug/uL, kept in light-block 
environment) were prepared by adding the indicated amounts to rich media; 
hydroxyurea (50 mM) was added to synthetic complete media. SGA screen, yeast spot 
assays and media used were as previously described (Rosonina et al. 2009, 2010). Cell 
cycle analysis was performed according to Zhang and Siede (2004). 
ChIP, RNA and protein analyses 
For ChIP analyses, 50-mL cultures were grown and cells were lysed by bead-
beating three times for one min each with one min in between in a cold room, as 
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previously described (Rosonina et al. 2014). After centrifugation, extracts were IPed 
with the appropriate antibody overnight, washed and treated with pronase, and DNA 
was extracted using phenol/chloroform. Samples were processed and analyzed, and 
data quantified, as previously described (Rosonina et al. 2009). Radioactive semi-
quantitative PCR was performed as previously described (Rosonina et al. 2012), using 
a region of chromosome VII as internal control. Statistical analyses were performed 
using a two-tailed Student’s t-test, with p-values indicated above bars in the graph. Error 
bars in graphs represent standard deviations of at least three experiments. 
Western blot and co-IP assays were as previously described (Rosonina et al. 
2009, 2010). Briefly, cell pellets from liquid cultures harvested between 0.5 and 1.0 
OD600 were washed with IP buffer (see Rosonina 2009) and cells lysed using glass 
beads. Lysates were removed from glass beads then centrifuged at high speed (15,000 
RPM, Eppendorf Centrifuge 5424) to pellet chromatin and debris. Supernatants were 
then centrifuged at high speed again and either diluted with 2X SDS loading buffer or 
IPed with sepharose beads and the appropriate antibody overnight at 4oC before 
addition of sample buffer. DNAse treatment of samples was based on NEB protocol 
M0303, where 1 unit of DNAse I per 50 uL of protein extract was added, and samples 
were incubated at 37oC for 10 minutes. This was performed before diluting samples with 
2X SDS loading buffer. The reaction was stopped by adding 2X SDS buffer and boiling 
samples for 5 minutes. 
Antibodies used for ChIP and western blotting were HA (ABM; ChIP and CoIP), 
HA (12AC5, a gift from Elizabeth Miller; Western), GAPDH (Sigma), MPK1 (sc-374434) 
and HOG1 (sc-165978) (Santa Cruz Biotechnology), Rpb3 (Biolegend), Y1P 3D12 
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(Active Motif), Ser2P (3E10, a gift from Dirk Eick), Ser5P (3E8; Millipore) and Rpb1 (y-
80; Santa Cruz). Primer sequences used for cloning, ChIP and RT-PCR analyses are 
available upon request. 
Random hexamers were used with total RNA for RT-PCR analyses, performed in 
triplicate.  
RNA sequencing and data analysis 
RNA sequencing was performed using Y1F and WT samples, in duplicate, and 
3’READS data were analyzed as previously described (Hoque et al. 2013). Briefly, 
3’READS reads were mapped to the S. cerevisiae genome (sacCer3) using bowtie2 
with local mode. Uniquely mapped reads (with MAPQ score > 10) that had at least two 
additional 5’ Ts after genomic alignments were assigned to genes by gene models from 
UCSC database (Tyner et al. 2017). CUTs and SUTs were annotated as described (Xu 
et al. 2009). DESeq was used to identify differentially expressed genes (Love et al. 
2014). Dysregulated genes were selected by FDR ≤ 0.05. 
Gene Ontology analysis  
Gene Ontology (GO) annotations were obtained from the Gene Ontology 
Consortium (Gene Ontology Consortium, 2015). GO entries were tested for significance 
of association with regulated genes using the hypergeometric test (Grossmann et al. 
2007). GO terms associated with more than 2,000 genes were discarded as too 
generic. To reduce redundancy, each represented GO term was required to have at 
least 30% of genes that had not been associated with another GO term or any other GO 
term with a more significant P-value (Ji and Tian, 2009). 
In vitro kinase assays 
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In vitro kinase assays were performed according to Campbell (2014). After 
growing cultures to 0.5 OD, SLT2-3HA cultures were incubated at 37oC for 1 hour, and 
HOG1-3HA cultures were grown in 0.8 M NaCl for 1 hour, cells were harvested and 
extracts prepared as described (Rosonina et al. 2009). Briefly, cells were agitated with 
glass beads in IP buffer for 30 minutes, then washed and pelleted. Cell extracts were 
IPed using HA antibody (ABM) and Sepharose-G beads at 4oC for two hours, then 
washed three times with lysis buffer and twice with kinase buffer (25 mM Tris pH 7.5, 5 
mM β-glycerophosphate, 2 mM DTT, 10 mM MgCl2, 10 mM NaF). Beads were then 
resuspended in 60 uL kinase buffer, with 200 nM GST-CTD (Hsin et al. 2014) and 10 
mM ATP. Reaction mixtures were incubated for two hours at 30oC with agitation every 
10 minutes to keep beads suspended. 2X SDS sample buffer was then added and 
samples were boiled for 5 minutes before analysis by SDS PAGE and Western blot. 
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Figure 1: RNAP II CTD Tyr to Phe substitution results in severe growth defects. (A) Tetrad 
dissection of heterozygous diploid Y1F CTD strain (Y1F). Y1F CTD in haploid tetrads marked 
with NAT resistance and is present in all small-size tetrads. Yeast spot assay comparing 
growth of WT, CONS, and two Y1F clones, with serial fivefold dilutions, on rich or synthetic 
complete (SC) medium at 30oC, or on rich medium at indicated temperature, for indicated 
number of days. (B) Cell-cycle assay showing unsynchronized cells stained with propidium
iodide, the two peaks representing cells in G1/G0 and G2, respectively. (C) Western blot 
analysis of cell lysates derived from WT and Y1F strains using antibodies recognizing the N-
terminus of Rpb1 (y80), unphosphorylated consensus repeats (8WG16), Ser2P (3E10 and 
H5), Ser5P (3E8), Tyr1P (3D12) and GAPDH as indicated. (D) Western blot analysis of an 
Rpb1 co-IP (using y-80 antibody), probing for Ctk1 interaction (using 3HA tagged Ctk1 and 
HA antibody) with RNAP II (normalized to Rpb3). 5% inputs shown. All results shown are 
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Figure 2: SGA analysis identifies suppressors of Y1F growth defects.  (A) List of genes 
showing synthetic rescue of Y1F strain in two SGA suppressor screens.  Genes displaying 
strongest interactions and involved in RNAP II transcription are shown (refer to Dataset 
S1 for a complete list). (B) Confirmation of genetic interaction between Y1F and 
SRB9/10/11 and UBP8. Strains of indicated genotypes were generated by recombinant 
transformation and growth compared by spot assay on rich medium with serial five-fold 
dilutions. YGL178C showed no interaction with Y1F in SGA screen and serves as a 
control. (C) ChIP analysis of Srb10/11 occupancy at promoter regions of indicated genes, 
using 3HA-tagged Srb10/11. Data normalized to WT signal at each gene; P values less 
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Figure 3: Expression of multiple genes is altered in Y1F.  (A) List of enriched GO terms 
through Gene Ontology Analysis. The numbers of significantly altered genes used for GO 
Analysis were 306 up-regulated, 324 down-regulated. Dataset S2 presents a complete list of 
expression changes for 5,925 genes. (B) RT-PCR analysis confirming changes in RNA levels 
for indicated genes between WT and Y1F strains. (IMD2 not detected in original RNA-seq
analysis). (C) Spot assays comparing growth of WT and Y1F strains, using serial five-fold 
dilutions, on rich and synthetic media with media containing indicated stress-inducing 
compounds.
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Figure 4: MAP Kinase Slt2 phosphorylates Tyr1 in vitro and in vivo. (A) In vitro kinase 
assay using 3HA-tagged Slt2 and Hog1 extracted and IPed from activated cells. 
Following incubation with GST-CTD, proteins were resolved by SDS-PAGE and blots 
probed with the indicated antibodies. Lanes are Slt2-HA (SLT2) and kinase-dead 
(KD), Hog1-HA (HOG1) and kinase dead (KD), beads and antibody control (BA) and 
GST-CTD alone (CTD). (B) Western blot of Tyr1P levels after stress induction. 
DMSO, calcofluor white (CFW) and phleomycin (Phl) are shown. Rpb1, Slt2, Hog1, 
and Rpb3 were also probed using their respective antibodies. Time points are 
untreated (Un), 15, 30, 45 and 60 minutes. (C) Quantification of (B). Signals were 
normalized individually to Rpb3 levels, then collectively to uninduced control. (D) 
Western blot and quantification of Tyr1P levels in isogenic deletion strains. Protein 
extracts from strains with either SLT2/HOG1 deletions (S∆/H∆; double, SH∆) or 
kinase-dead mutations (SM/HM) were blotted using 3D12 and normalized to WT. (E) 
Western blot of Tyr1P levels after heat stress (37oC); signals normalized as in (B). All 
results shown are representative of three independent experiments; data are 
represented as mean +/- SE of three independent experiments.
Slt2
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Figure 5: Differential association of Slt2 with WT and Y1F RNAP II. (A) Western 
blot analysis of a Rpb1 co-IP (using y-80 antibody), probing for Slt2 interaction with 
RNAP II (normalized to Rpb3). 5% inputs shown. (B) Western blot analysis of a 
Slt2-3HA co-IP, probing for total Rpb1 (y80), Tyr1-P Rpb1 (3D12) and Ser2-P Rpb1 
(3E10), using Rpb3 as control for normalization. Untreated (Un), heat treated 
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Figure 6: RNAP II Tyr1 and Slt2 affect Nrd1 recruitment to RNAP II and chromatin. 
(A) Western blot analysis of Nrd1 levels after Rpb1 co-IP (using y-80 antibody), 
with quantification. Nrd1 interaction with RNAP II quantified using Rpb3. (B) 
Western blot analysis of Rtt103 levels after Rpb1 co-IP (using y-80 antibody), with 
quantification. Rtt103 interaction with RNAP II quantified using Rpb3. (C) ChIP
analysis of Nrd1 occupancy at promoter regions of indicated genes in WT and 
Y1F strains. (D) ChIP analysis of Nrd1 occupancy at promoter and body regions 
of model gene FKS2, before and after heat stress. (E) ChIP analysis of Slt2 
occupancy at promoter and body regions of model gene FKS2, before and after 
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Figure 7:  Role of CTD Tyr1 and Slt2 kinase in activating transcription of stress-inducible 
genes. In the absence of activation by a stress-induced signaling cascade, Slt2 is 
inactive and Tyr1 is not phosphorylated. The Nrd1-containing NNS complex is thus 
recruited to a primarily Ser5P CTD and transcripts are prematurely terminated and 
degraded. Activation of Slt2 enables the kinase to associate with RNAP II and 
Mediator/SBF, promoting Srb10/11 degradation and RNAP II Tyr1 phosphorylation. This 
combination of events facilitates activation and prevents termination factor (e.g., NNS) 
association with the CTD until the 3’ end, when Tyr1 is dephosphorylated, the transcript 
3' processed and transcription terminated.
Figure S1
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Figure S1: (A) Tetrad dissection of heterozygous diploid Y1F CTD strain (Y1F). Y1F 
CTD in haploid tetrads was marked with NAT resistance and was present in all small-
size tetrads. (B) Liquid growth curve for WT and Y1F strains in rich medium over 48 
hours. Results are averages of three biological replicates for each strain. 
Figure S2




















































































Figure S2: (A) Sample tetrad dissection results for SGA 
genes UBP8, SSN8, SSN2, and SSN3. Asterisk (*) 
indicates NAT-/G418-resistant double mutant containing 
both gene deletion (G418 resistance) and Y1F 
polymerase (NAT resistance). (B) Liquid growth curve for 
suppressors of Y1F strains (UBP8, SRB11, SRB9) in rich 
medium over 48 hours (growth of Y1F from Figure S1B is 
shown for comparison). Results are averages of three 















































CDS 65 52 3052
Intronic 4 0 23
First 77 190 3089
Middle 94 121 4326
Last 257 51 3048
Single 17 17 325
UA 14 4 951
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Figure S3: Additional analyses performed for 3’READS analysis. (A) Up- and down-
regulation of poly(A) site usage in Y1F strain compared to WT. Labels “First” through 
“Single” are found in 3’ UTR of genes. (B) Number of poly(A) site changes from (A) in 
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Figure S4: Correlation data for 3’READS analysis. (A) Correlation of significant genes 
(up-regulated/down-regulated) between WT and Y1F replicates. (B) Correlation for 
number of reads of genes in samples.
Figure S5
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Figure S5: Analysis of CUTs and SUTs between WT and Y1F for 3’READS analysis.
Figure S6
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Figure S6: Comparison of data between Mayer et al. 2012 and 3’READS data from this 
paper. Tyr1 ChIP signal intensity is compared between up-regulated, down-regulated, and 





Galactose NaCl (0.4 M) Low Phosphate
147
Figure S7: Additional stressors tested for changes in Y1F growth. Media containing 
galactose as the sole carbon source, or 0.4 M NaCl, or media depleted of phosphate 
were used to determine Y1F growth compared to rich media at the indicated time point. 










Figure S8: In vitro kinase assays with Ctk1 and Kin28. Both 3HA-tagged kinases were 
extracted from yeast and following IP incubated with GST-CTD as in Figure 4. Blots 
with Tyr1p- (3D12), Ser2p- (3E10), and Ser5p- (3E8) antibodies are shown. Lanes are 
Ctk1-HA (CTK1), Kin28-HA (KIN28), beads and antibody control (BA), and GST-CTD 
alone (CTD).
Strain Genotype
BY4741 MATa his3del1 leu2del0 met15del0 ura3del0
BY4742 MATalpha his3del1 leu2del0 lys2del0 ura3del0
BY4743
(Diploid) MATa/MATalpha his3del1/his3del1 leu2del0/leu2del0 lys2del0/+
met15del0/+ ura3del0/ura3del0
The following strains are haploids derived from BY4743
NYYM203A rpb1::rpb1-CTD(Y1F)26-NatR  (Y1F 1)
NYYM204D rpb1::rpb1-CTD(Y1F)26-NatR  (Y1F 2)
NYYM205A rpb1::rpb1-CTD(CONS)26-NatR
NYYM208A ygl178cdel::kanMX  rpb1::rpb1-CTD(Y1F)26-NatR
NYYM209A ygl178cdel::kanMX
NYYM210C ubp8del::kanMX  rpb1::rpb1-CTD(Y1F)26-NatR
NYYM211A ubp8del::kanMX
NYYM212B ssn3del::kanMX  rpb1::rpb1-CTD(Y1F)26-NatR
NYYM213A ssn3del::kanMX
NYYM214A ssn8del::kanMX  rpb1::rpb1-CTD(Y1F)26-NatR
NYYM215A ssn8del::kanMX
NYYM216B ssn2del::kanMX  rpb1::rpb1-CTD(Y1F)26-NatR
NYYM217A ssn2del::kanMX
NYYM218D SSN8::3HA HIS3+  rpb1::rpb1-CTD(Y1F)26-NatR
NYYM219A SSN8::3HA HIS3+ 
NYYM220B SSN3::3HA HIS3+  rpb1::rpb1-CTD(Y1F)26-NatR
NYYM221A SSN3::3HA HIS3+ 
NYYM222A SLT2::3HA HIS3+  rpb1::rpb1-CTD(Y1F)26-NatR
NYYM223A SLT2::3HA HIS3+ 
NYYM224A slt2del::kanMX
NYYM225C slt2del::kanMX [pRS315-slt2(K54R)-3HA] LEU2+ 
NYYM226A HOG1::3HA HIS3+ 
NYYM227A CTK1::3HA HIS3+ 
NYYM228A KIN28::3HA HIS3+ 
NYYM229A hog1del::kanMX
NYYM230A slt2del::kanMX hog1del::NatR
NYYM231C NRD1::3HA HIS3+  rpb1::rpb1-CTD(Y1F)26-NatR
NYYM232A NRD1::3HA HIS3+
NYYM233B RTT103::3HA HIS3+  rpb1::rpb1-CTD(Y1F)26-NatR
NYYM234A RTT103::3HA HIS3+
The following strains were derived from the S288C background





Table S1: A list of strains used for this study.
